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Executive summary
This is the second national clinical audit on 
perinatal mortality in Ireland using the NPEC 
data collection tool and classification system. 
Anonymised data were reported by the 20 
Irish maternity units on a total of 485 perinatal 
deaths occurring in 2012 and arising from 
71,755 births of at least 24 weeks gestation 
or at least 500g birthweight. Stillbirths, early 
neonatal and late neonatal deaths accounted 
for 304 (62.7%), 141 (29.1%) and 40 (8.2%) of 
the 485 deaths, respectively.
The perinatal mortality rate was 6.2 per 
1,000 births in 2012; corrected for congenital 
malformation, the rate was 4.1 per 1,000 
births; the stillbirth rate was 4.2 per 1,000 
births; and, the early neonatal death rate 
was 2.0 per 1,000 live births. International 
comparisons are hampered by variation 
in definitions, availability of screening 
programmes for congenital anomalies and 
national legislation on abortion. Nevertheless, 
the Irish perinatal mortality rates compare 
favourably with those of countries in the UK 
and Europe. The year 2012 is the fifth year 
the NPEC has reported national perinatal 
mortality rates and while this period is too 
short to establish trends, it is promising 
that the observed rates have decreased by 
approximately 10%.
There was approximately a threefold variation 
in perinatal mortality rates across the 20 Irish 
maternity units. This level of variation is in line 
with statistical expectations, when looking 
at one year. However, further investigation 
is required to establish the extent to which 
it reflects differences in the risk profiles of 
mothers delivering at the maternity units. 
Consideration is also given in this year’s report 
to the influence of in utero transfer cases on 
unit-specific perinatal mortality rates.
Of the 445 perinatal deaths in 2012, there 
were 26 cases (5.8%) where the care of 
the mother was transferred in utero, all but 
one to a tertiary maternity hospital. Twenty-
four of the 26 in utero transfer cases were 
delivered in one of the country’s four large 
maternity hospitals, accounting for 10.5% of 
the 229 perinatal deaths for these hospitals 
in 2012. This proportion ranged from 4.4% 
for one hospital to 14.8% for another. This is 
the reduction that would be observed in the 
perinatal mortality rate for these hospitals if 
perinatal deaths following in utero transfer 
were excluded.
Major congenital anomaly was the main 
cause of perinatal death, accounting for 26% 
of stillbirths, 48% of early neonatal deaths and 
38% of late neonatal deaths. These proportions 
are higher than reported in most European 
countries where about 15-20% of stillbirths 
and one-quarter of early neonatal deaths are 
due to congenital anomalies.2 A chromosomal 
disorder was most often implicated in cases 
of stillbirth (48%) and early neonatal death 
(25%) when a major congenital anomaly was 
present. The proportion of stillbirths due to 
major congenital anomaly has increased in 
Ireland from 19% in 2008 to 26% in 2012.
Specific placental conditions (24%) were the 
other major cause of stillbirth; mechanical 
factors, antepartum or intrapartum 
haemorrhage and infection were the 
main cause of 8%, 7% and 5% of stillbirths, 
respectively. The NPEC Classification System 
limited the proportion of unexplained 
stillbirths to 23% compared to approximately 
50% previously reported using the 
Wigglesworth Classification System. This has 
positive implications for the identification of 
modifiable factors that may prevent stillbirth.
2 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available 
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After major congenital anomaly, respiratory 
disorders were the other main cause of early 
(31%) and late (23%) neonatal deaths. The 
vast majority of these deaths were classified 
as due to severe pulmonary immaturity.
The rate of autopsy following perinatal death 
in 2012 was 45%. This is slightly higher than 
in 2011 (41%) but lower than in 2010 (48%). 
The rate of autopsy in stillbirths has shown 
a gradual decline since 2008 but is always 
higher than the rate for early neonatal deaths. 
In 2012, an autopsy was undertaken following 
48% of stillbirths and 39% of early neonatal 
deaths. When we assessed the perinatal 
deaths that did not receive an autopsy, an 
offer of an autopsy was made in 78% of cases.
The importance of placental histology in 
evaluating causes of stillbirths has been well 
documented. In this regard, it is a positive 
finding that a placental histology examination 
was conducted in almost all stillbirths (96%) 
and for 80% of early neonatal deaths in 2012. 
This is higher than in 2011 when placental 
histology was performed in 93% of stillbirths 
and 69% of neonatal deaths.
The age profile of mothers who experienced 
perinatal loss in 2012 was similar to that of 
all mothers who gave birth in the country that 
year although there was an overrepresentation 
of mothers aged at least 40 years, as there 
was in 2011. In terms of ethnicity and 
occupation, while the numbers involved were 
small, ethnic minorities and the unemployed 
were overrepresented in the mothers who 
experienced perinatal deaths. Monitoring 
the socio-economic status of the pregnant 
population in Ireland is challenging as these 
data are not routinely captured in Irish 
maternity records but further efforts must be 
made if we are to better understand how social 
disadvantage impacts on perinatal outcomes.
Recording the smoking status of pregnant 
women also presents challenges. In this 
report, 17% of the mothers were smokers at 
the time of their first antenatal booking visit 
and the data suggested that 10% subsequently 
stopped smoking. This would put the proportion 
who smoked throughout their pregnancy in 
line with that reported for pregnant populations 
in UK countries (12-19%). Smoking cessation 
requires priority; given that it is one of the most 
effective health interventions for improving 
perinatal outcomes.
Body mass index (BMI) was reported for 78% 
of the mothers who experienced a stillbirth 
or early neonatal death in 2012, up from a 
reporting rate of 67% in 2011. Just over half of 
these women were either overweight (33%) or 
obese (20%) which is in line with the findings 
for women from an earlier general population 
study though marginally higher than the 
prevalence of maternal obesity reported by 
two Irish studies of mothers at first antenatal 
booking visit.3,4 Efforts will be made to further 
improve the completeness of data on BMI 
with regard to this clinical audit but national 
data on the BMI status of all pregnant women 
at first antenatal booking visit and during 
pregnancy is required in order to establish 
its association with perinatal mortality and 
morbidity in Ireland.
Comparing the mothers who experienced a 
perinatal death to the mothers of all births 
in 2012 in terms of parity, there was a slight 
overrepresentation of women who were 
nulliparous (42% versus 39%) or Para 3+ (13% 
versus 9%) as was the case in 2011. Of the 
women with previous pregnancies, 19% had a 
previous caesarean delivery and 6% had had 
pre-eclampsia.
One in nine perinatal deaths (11%) arose from 
multiple birth deliveries which is three times the 
proportion of multiples among all births in 2012 
(4%); this is similar to the findings for 2011.
Twenty-nine mothers (7%) were admitted to 
the high dependency unit (HDU) following the 
delivery. Seven mothers (2%) were admitted 
to the intensive care unit.
3 Fattah C, Farah N, Barry S, O’Connor N, Stuart B, Turner MJ. Maternal weight and body composition in the first trimester of pregnancy. Acta Obstet Gynecol 
Scand 2010;89:952-5.
4 Lynch CM, Sexton DJ, Hession M, Morrison JJ. Obesity and mode of delivery in primigravid and multigravid women. Am J Perinatol 2008;25:163-7.
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The relevance of birthweight in perinatal 
mortality is highlighted again in this 
year’s report. As well as findings from the 
clinical audit itself, the invited commentary 
contributed to this year’s report by Dr Julia 
Unterscheider, Maternal Fetal Medicine Fellow 
at the Royal College of Surgeons in Ireland, is 
on the topic of fetal growth restriction and the 
risk of perinatal mortality.
This year’s report includes a section on 
perinatal deaths associated with intrapartum 
events in order to raise awareness of the 
occurrence of unexpected stillbirths and early 
neonatal deaths of normal birthweight babies 
with a term or near full term gestational age. 
There were 24 such deaths in 2011 (n=11) 
and 2012 (n=13), suggesting a rate of 0.16 per 
1,000 births or one in 6,084 births in Ireland. 
While the 13 deaths in 2012 accounted for 
just 2.9% of the 445 perinatal deaths reported 
to this audit for the year, they accounted 
for one in eight (12.3%) of the 106 cases 
of perinatal death with normal birthweight 
and gestation of at least 37 weeks. A high 
proportion of the deaths was associated 
with hypoxic ischaemic encephalopathy and 
had no reported antecedents or associated 
obstetric factors. This suggests the need for 
further investigation of unexpected perinatal 
deaths of intrapartum origin. A retrospective 
indepth review of a case series may be the 
most informative approach, in particular with 
regard to quality of care.
There were 40 late neonatal deaths in 2012 
reported to the NPEC, a number that is 
consistent with the annual number of late 
neonatal deaths reported by the Central 
Statistics Office in recent years. Currently in 
Ireland, there is no formal system by which 
maternity units are notified of the outcomes 
for infants referred to paediatric units, 
which could result in underreporting of late 
neonatal deaths to the NPEC. We are working 
with colleagues in the relevant hospitals 
(maternity and paediatric) to address this 
issue.
In summary, the findings of this national 
clinical audit of perinatal mortality highlight 
the clear and inherent need for on-going audit 
in order to identify key factors impacting on 
adverse perinatal outcomes. The methodology 
for data collection and classification, adapted 
by the NPEC, with the kind permission of the 
Centre for Maternal and Child Enquiries in 
the UK5 not only facilitated the collection of 
multiple clinical and demographic factors, 
but it also identified current clinical practices 
in the management of women experiencing 
perinatal loss in Ireland. The use of the NPEC 
Classification System substantially reduced 
the proportion of unexplained stillbirths by 
identifying clinical and pathological factors 
impacting on such deaths that previously 
have been labelled as ‘unexplained’. This will 
enhance clinical interpretation of perinatal 
deaths occurring in Ireland which will 
further assist in informing clinical practice, 
public health interventions and counselling 
of prospective parents. Furthermore, the 
wide breath of data collected by the NPEC 
will facilitate future comparisons with 
other developing classification systems 
internationally.
5 Centre for Maternal and Child Enquiries (CMACE) Perinatal Mortality 2008: United Kingdom. CMACE: London, 2010
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Recommendations
•	 Improved	 antenatal	 detection	 and	 increased	 
 surveillance of fetal growth restriction (FGR) with 
 timely delivery is a preventative strategy to reduce 
 perinatal morbidity and mortality. A standardized 
 definition and diagnosis of FGR with an appropriate 
 care model recommended by national clinical 
 guidelines should be referred to. The use of 
 customized centile growth charts should be 
 considered.
•	 All	pregnant	women	should	have	an	accurate	weight,	 
 height and BMI measured and documented in the 
 maternity records both at their first antenatal visit 
 and during the last trimester in order to ascertain 
 the impact of maternal weight on perinatal mortality 
 in Ireland.
•	 Health-care	providers	should	increase	their	efforts	to	 
 assess and record the smoking status of all pregnant 
 women in Ireland both at the antenatal booking 
 visit and during the third trimester. The availability 
 of smoking cessation programmes during pregnancy 
 needs to be intensified.
•	 Consideration	 should	 be	 given	 to	 the	 national	 
 collection of a broader range of data points in the 
 maternity records to better understand the impact 
 of socio-economic factors on perinatal heath in 
 Ireland. Additional data points, including the 
 expectant mother’s ethnicity, level of education and 
 the economic status of both mother and partner, 
 should be recorded in accordance with the Central 
 Statistics Office coding frames.
•	 A	 retrospective	 indepth	 review	 of	 a	 case	 series	 of	 
 unexpected perinatal deaths of intrapartum origin 
 may be warranted to provide additional information 
 with regard to quality of care.
 
•	 The	maternity	hospital	of	delivery	should	be	notified	 
 of any neonatal or infant death occurring in a 
 paediatric centre/unit.
•	 A	 multidisciplinary	 approach,	 including	 perinatal	 
 pathology, is recommended in the audit of perinatal 
 deaths at unit level.
•	 Further	 research	 exploring	 factors	 impacting	 on	 
 declining autopsy rates, particularly in the case of 
 neonatal deaths, is warranted.
•	 All	 maternity	 units	 should	 continue	 to	 collect	 and	 
 submit anonymised data on perinatal mortality to 
 inform this national clinical audit. This should include 
 all neonatal deaths regardless of gestational age or 
 weight at birth. In the case of stillbirths, all babies 
 from 24 weeks gestation or with a birthweight of 
 ≥500g should be reported.
Based on the findings of this report, the NPEC makes the following 
recommendations. Some recommendations from the last report are restated, 
as improvements remain to be seen particularly in the collation of data on 
Ireland’s pregnant population:
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Data recording
In 2012, there were 20 maternity units in 
Ireland. Anonymised data on the perinatal 
deaths that occurred between January 1 and 
December 31 2012 were collected from all 20 
units using a standardised notification form 
(see Appendix C). Figure 1 illustrates the flow 
of information involved. To ensure accuracy of 
information, missing or incomplete data were 
sought from respective maternity units.
Definitions and terminology
While individual units define perinatal cases 
similarly, there is some variation. To allow for 
comparison across all units the NPEC used 
the following definitions for the current report:
Stillbirth: Baby delivered without signs of life 
from 24 weeks gestation or with a birthweight 
≥500g.6
Early neonatal death: Death of a live born baby 
occurring within 7 completed days of birth.
Late neonatal death: Death of a live born baby 
occurring after the 7th day and within 28 
completed days of birth.
Live birth: Live birth refers to the complete 
expulsion or extraction from its mother of 
a product of conception, irrespective of the 
duration of the pregnancy, which, after such 
separation, breathes or shows any other 
evidence of life - e.g. beating of the heart, 
pulsation of the umbilical cord or definite 
movement of voluntary muscles - whether 
or not the umbilical cord has been cut or the 
placenta is attached. Each product of such a 
birth is considered live born.7
Total births: For the purpose of calculating 
perinatal mortality rates, the denominator 
used was the number of births (live birth 
and stillbirths) from 24 weeks gestation or 
birthweight ≥500g.
Stillbirth rate: Number of stillbirths per 1,000 
births (live births and stillbirths from 24 
weeks gestation or weighing ≥500g).
Methods
Figure 1: Flow of information in the NPEC data collection process.
6 Stillbirths Registration Act, 1994.
7 World Health Organisation. Available at: http://www.who.int/healthinfo/statistics/indmaternalmortality/en/
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Neonatal death rate: Number of neonatal 
deaths per 1,000 live births (from 24 weeks 
gestation or weighing  ≥500g).
Overall perinatal mortality rate (PMR): 
Number of stillbirths and neonatal deaths per 
1,000 births (live births and stillbirths from 
24 weeks gestation or weighing ≥500g).
Adjusted PMR: Perinatal mortality rate 
excluding perinatal deaths associated with or 
due to a congenital malformation.
Booking: Some data sought by the NPEC 
Perinatal Death Notification Form relate to the 
time of booking. Booking in this regard relates 
to the mother’s first antenatal visit at the 
maternity unit.
In utero transfer: The NPEC Perinatal Death 
Notification Form records the intended place 
of delivery at the time of the mother’s first 
antenatal visit and the place where the baby 
was ultimately delivered. For cases where the 
intended place of delivery at booking differed 
from the actual place of delivery it is presumed 
that the care of the mother was transferred in 
utero, i.e. the mother was transferred to the 
care of another maternity unit where her baby 
was delivered.
Parity: The number of completed pregnancies, 
whether live birth or stillbirth, of at least 24 
weeks gestation or with a birthweight ≥500g. 
We refer to parity prior to the pregnancy that 
resulted in a perinatal loss in 2012.
Gravida: The number of times the mother has 
been pregnant, irrespective of duration. We 
refer to gravida prior to the pregnancy that 
resulted in a perinatal loss in 2012.
Classification of death
The NPEC data collection form requests 
contributors to identify maternal, fetal 
and neonatal conditions, using specific 
categories, which caused or were associated 
with the death. The unit contributor is also 
requested to assign the principal cause of 
death with reference to the post mortem and 
placental pathology if performed. Guidance 
and definitions for completing specific 
categories are described in Appendix D. 
Briefly described; categories include both 
pathophysiological entities and clinical 
conditions present at time of death including 
placental pathology and Intra-Uterine Growth 
Retardation (IUGR). Classification of stillbirths 
was made using the NPEC maternal and fetal 
classification system. In the case of neonatal 
deaths, the NPEC neonatal classification 
system was used to attribute the main cause 
of death and the NPEC maternal and fetal 
classification system was used to identify 
the main obstetric condition or sentinel 
event associated with the death. A notable 
difference in the NPEC neonatal classification 
system is that neonatal deaths occurring after 
22 weeks gestation, previously attributed to 
prematurity, would most often be captured 
under the subcategory of ‘severe pulmonary 
immaturity’.
Rate calculations
To assess perinatal mortality, overall and 
unit-specific perinatal mortality rates (PMRs) 
per 1,000 births and corresponding 95% 
confidence intervals based on the Normal 
approximation of the Poisson distribution 
were derived. Stillbirth, neonatal and corrected 
PMRs, which exclude deaths associated with 
or due to a congenital malformation, were also 
calculated. Denominator data on the number 
of live births and stillbirths were provided 
directly by individual maternity units. Perinatal 
deaths are included in a maternity unit’s rate 
if: (i) the baby was delivered in the maternity 
unit; (ii) the unit was the intended place of 
delivery but the baby was born before arrival; 
(iii) the mother had not booked to deliver in a 
maternity unit but presented to the unit after 
unattended delivery in the community.
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Funnel plots
Variations in PMRs between maternity units 
could potentially be due to random chance or 
reflect differences in baseline characteristics 
of the childbearing population. For this reason, 
funnel plots were used to assess performance 
outcomes for individual units in comparison 
to the overall average.8 In brief, the plot is a 
scatter diagram of individual maternity unit 
mortality rates against the number of births 
within that unit. The overall mortality rate 
is indicated by the solid straight line and 
the corresponding 95% confidence interval 
is indicated by the curved dashed line. The 
confidence interval is wider for smaller units, 
which are more prone to variable estimates 
and gradually narrows as the unit size 
increases, hence, giving the diagram a ‘funnel’ 
shape. Maternity units with mortality rates 
lying outside the 95% confidence interval are 
statistically significantly different from the 
overall average. In general, one of 20 units 
would be expected to lie outside the 95% 
confidence interval by chance alone.
Birthweight centile
We have produced charts in this year’s report 
to highlight the issue of failure of fetal growth 
in utero in relation to the stillbirths and early 
neonatal deaths that occurred in Ireland 
in 2012. To do so, we used the Gestation 
Related Optimal Weight (GROW)9 software 
and coefficients derived from the multiple 
regression analysis of data on 11,072 births 
in six maternity units in Dublin, Galway, 
Limerick and Belfast in 2008-2009.10
The regression analysis determined the 
Term (i.e. 40 weeks) Optimal Weight (TOW) 
in Ireland to be 3,490.7g. The normal range 
(i.e. the range from the 10th centile weight 
to the 90th centile weight) around the TOW 
was then calculated and the recommended 
proportionality growth function was applied 
to the TOW, the 10th centile term weight 
and the 90th centile term weight in order to 
determine the optimal weight and normal 
range at all gestations (21-44 weeks for the 
stillbirths and early neonatal deaths in Ireland 
in 2012). These steps are described in detail 
in the GROW documentation.
Customised birthweight centiles were also 
derived using the GROW software. There was a 
high level of missing data for maternal height 
and weight with one or both unknown for 143 
(32.1%) mothers. For these cases, we used 
the median height and weight of the mothers 
with complete data. As a result, it was possible 
to calculate customised birthweight centiles 
for 438 of the 445 mothers (98.4%).
8 Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
9 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
10 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. The customized fetal growth 
potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
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1. Main findings
This section of the report provides details of the 
perinatal mortality rate (PMR), maternal and 
infant characteristics and autopsy uptake. In line 
with previous reports, the findings provided in 
this section relate to stillbirths and early neonatal 
deaths only. Separate sections are then provided 
for stillbirths, early neonatal deaths and late 
neonatal deaths describing clinical management 
and the main cause of death based on the NPEC 
Classification System.
In 2012, the 20 Irish maternity units reported 
71,755 births weighing ≥500g or ≥24 weeks 
gestation, of which 485 were subsequently 
classified as perinatal deaths. Stillbirths, early 
neonatal and late neonatal deaths accounted for 
304 (62.7%), 141 (29.1%) and 40 (8.2%) of the 
485 deaths, respectively.
The stillbirth rate was 4.2 per 1,000 births and 
the early neonatal death rate was 2.0 per 1,000 
live births (Table 1.1). The overall PMR was 6.2 
deaths per 1,000 births. When corrected for 
congenital malformation, the PMR was reduced 
to 4.1 deaths per 1,000 births.
Table 1.2 compares perinatal statistics across 
the five-year period 2008-2012. There are 
some issues relevant to the comparability of 
the data. Data were based on 19 maternity 
units for 2009 and 2010 but were based on 
all 20 maternity units for other years. Also 
for 2008-2010, the data for stillbirths were 
based on birthweights ≥500g whereas for 
2011 and 2012 the data for stillbirths were 
based on birthweights ≥500g or ≥24 weeks 
gestation. Nevertheless, the reported figures 
show some evidence of a trend of decreasing 
perinatal mortality rates though the 2011 and 
2012 rates are almost identical.
Table 1.1: Frequency and rate of perinatal mortality outcomes, 2012
Table 1.2: Comparison of perinatal statistics, 2008-2012
 Number Rate per 1,000 (95% CI)
Total births (≥500g/≥24 weeks) 71,755 
Stillbirths 304 4.2 (3.8-4.7)
Early neonatal deaths 141 2.0 (1.6-2.3)
Perinatal deaths 445 6.2 (5.6-6.8)
Corrected perinatal deaths 297 4.1 (3.7-4.6)
 2008 2009 2010 2011 2012
Total births (N) 75,421 70,250 70,182 74,265 71,755
Total perinatal deaths (N) 512 477 463 456 445
Stillbirth rate 4.7 4.8 4.6 4.3 4.2
Neonatal death rate 2.1 2.0 2.0 1.9 2.0
Uncorrected PMR (95% CI) 6.8 (6.2-7.4) 6.8 (6.2-7.4) 6.6 (6.0-7.2) 6.1 (5.6-6.7) 6.2 (5.6-6.8)
Corrected PMR (95% CI) 4.9 (4.4-5.4) 4.8 (4.3-5.3) 4.5 (4.0-5.0) 4.1 (3.6-4.5) 4.1 (3.7-4.6)
Note: Corrected perinatal deaths exclude deaths associated with or due to a congenital malformation. Abbreviation: 95% CI, 
95% confidence interval
Note: 2009-2010 data are based on 19 maternity units whereas others years’ data are based on 20 maternity units. Rates are 
per 1,000 births. Abbreviation: PMR, perinatal mortality rate; 95% CI, 95% confidence interval
Perinatal mortality rate
Comparison of perinatal mortality, 2008-2012
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The uncorrected PMR across the 20 Irish 
maternity units ranged from 3.4 to 8.9 per 
1,000 births (Table 1.3); the corrected PMR 
ranged from 2.4 to 7.0 per 1,000 births. 
Thus, there was approximately a threefold 
difference between the lowest and highest 
PMRs. This level of variation is to be expected 
when examining rates based on relatively 
small numbers in a single year.
While there was no change in the corrected 
PMR between 2011 and 2012 at the national 
level, there were of course fluctuations at the 
level of the individual maternity units. There 
was little correlation between the unit-specific 
corrected PMR in 2011 and 2012. Indeed, the 
rate for five units in 2012 was approximately 
twice or half the rate for the same unit in 
2011. Again, such variation in rates is to be 
expected given the numbers upon which the 
rates are based.
Table 1.3: Perinatal mortality rates across 20 Irish maternity units in 2011 and 2012
Unit  Uncorrected PMR (95% CI) Corrected PMR (95% CI)
  2012 2012 2011
1  8.9 (4.3-13.6) 5.4 (1.8-8.9) 2.3 (0.0-4.6)
2  8.3 (6.4-10.2) 5.5 (4.0-7.1) 4.6 (3.2-6.0)
3  8.1 (3.6-12.6) 4.4 (1.1-7.6) 4.4 (1.1-7.8)
4  7.8 (3.8-11.8) 6.2 (2.6-9.8) 5.4 (2.1-8.6)
5  7.6 (3.4-11.8) 7.0 (3.0-11.1) 5.4 (2.0-8.8)
6  6.9 (2.3-11.5) 3.1 (0.0-6.2) 2.6 (0.0-5.6)
7  6.4 (4.7-8.1) 4.0 (2.6-5.3) 3.7 (2.4-5.0)
8  6.3 (3.7-8.9) 4.9 (2.6-7.2) 4.7 (2.5-6.9)
9  6.2 (3.5-8.9) 3.3 (1.3-5.2) 3.5 (1.5-5.5)
10 5.9 (4.3-7.5) 3.8 (2.5-5.1) 4.1 (2.8-5.4)
11 5.9 (2.9-8.8) 5.2 (2.4-7.9) 3.6 (1.3-5.9)
12 5.9 (3.7-8.1) 4.3 (2.4-6.1) 4.4 (2.6-6.3)
13 5.5 (2.3-8.7) 3.7 (1.1-6.3) 2.7 (0.5-4.9)
14 5.3 (2.3-8.4) 3.1 (0.8-5.5) 5.8 (2.7-8.9)
15 5.3 (3.7-6.8) 3.3 (2.0-4.5) 3.8 (2.4-5.1)
16 4.8 (1.6-8.0) 2.7 (0.3-5.0) 6.0 (2.5-9.4)
17 4.7 (1.6-7.8) 3.1 (0.6-5.7) 1.5 (0.0-3.1)
18 3.9 (1.1-6.6) 2.4 (0.3-4.6) 5.1 (2.0-8.2)
19 3.4 (0.0-6.8) 2.6 (0.0-5.5) 2.4 (0.0-5.2)
20 3.4 (0.8-6.0) 2.4 (0.3-4.6) 3.1 (0.8-5.4)
All 6.2 (5.6-6.8) 4.1 (3.7-4.6) 4.1 (3.6-4.5)
Note: Rates per 1,000 births. Corrected PMR excludes deaths associated with or due to a congenital malformation. 
Abbreviation: PMR, perinatal mortality rate; 95% CI, 95% confidence interval
Variation by maternity unit
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Figure 1.1: Funnel plot of corrected perinatal mortality rate for Irish maternity units, 2012
Figure 1.2: Funnel plot of stillbirth rate for Irish maternity units, 2012 
While differences in corrected PMRs were 
identified between units, there were no 
statistically significant outliers. The solid 
straight line in Figure 1.1 represents the overall 
corrected PMR (4.1 deaths per 1,000 births) 
and the curved dashed lines represent the 
95% confidence interval around the overall rate 
adjusted for the number of births at the individual 
unit. In 2012, all unit-specific corrected PMRs fell 
within the 95% confidence interval.
In Figure 1.2, the solid straight line represents 
the overall stillbirth mortality rate of 4.2 per 
1,000. For all 20 maternity units the stillbirth 
rate was within the limits of the 95% confidence 
interval.
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Figure 1.3: Funnel plot of early neonatal mortality rate for Irish maternity units, 2012
The solid straight line in Figure 1.3 represents 
the overall neonatal mortality rate of 2.0 per 
1,000 live births. The neonatal mortality rate 
from one of the individual units was outside 
the upper limit of the confidence interval 
indicating that it was statistically significantly 
higher than the overall rate. A similar 
observation was made for 2011 whereby a 
different unit had a neonatal mortality rate 
above the upper limit. Statistically it can be 
expected for one in 20 observations to be 
outside the 95% confidence range. No unit has 
been outside the range in successive years. 
The profile of mothers delivered may differ 
across Irish maternity units and this may 
explain variation in perinatal mortality rates. 
However, to establish this requires more 
detailed information on all mothers delivered 
at Irish maternity units than is currently 
available.
In Ireland, women with high risk pregnancies 
may be transferred to the care of tertiary 
maternity units with facilities for specialist 
fetal medicine. Of the 445 perinatal deaths 
in 2012, there were 26 cases (5.8%) where 
the care of the pregnant woman was 
transferred in utero. The 26 in utero transfer 
cases resulted in nine stillbirths (34.6%) 
and 17 early neonatal deaths (65.4%). Major 
congenital anomaly was the cause of two of 
the stillbirths and nine of the early neonatal 
deaths. For all but one case the mother was 
referred before the onset of labour and to a 
tertiary maternity unit. Twenty-four of the 26 
in utero transfer cases were delivered in one 
of the country’s four large maternity hospitals. 
For these hospitals in 2012, 10.5% of their 229 
perinatal deaths arose from in utero transfer 
cases. This proportion ranged from 4.4% for 
one hospital to 14.8% for another. This shows 
the reduction that would be observed in the 
perinatal mortality rate for these hospitals if 
perinatal deaths following in utero transfer 
were excluded.
In utero transfer
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Age
The mothers who experienced perinatal loss 
in 2012 ranged in age from early teenage 
years through to the mid-forties. Their age 
distribution broadly reflected that of the 
population of mothers who gave birth in 
Ireland (Table 1.4). Mothers aged at least 40 
years made up 5.5% of the population who 
gave birth in 2012 but 10% of the mothers 
who experienced perinatal loss. There was a 
somewhat older age profile among mothers 
who experienced a stillbirth. Forty percent 
were over 35 years of age compared to 30% of 
those who experienced a neonatal death.
Ethnicity
Three-quarters of the mothers who 
experienced perinatal loss were of white Irish 
ethnicity. This is essentially the proportion of 
white Irish women in the female population 
aged 15-49 years enumerated by the National 
Census 2011. While the numbers involved 
were small, Irish Traveller, Asian and Black 
ethnicities were overrepresented in the 
mothers who experienced perinatal deaths, 
together accounting for 10% of these mothers 
compared to 5% of the female 15-49 year-old 
population. Ethnicity was not recorded for 
5.9% of cases in 2011 but only 0.7% in 2012.
Maternal characteristics
 Age group Perinatal deaths Perinatal deaths All births11 Stillbirths Neonatal deaths
  (N=454) (N=440*)  (N=300) (N=140)
  2011 2012 2012 2012 2012
 <20yrs 12(2.6) 14(3.2) 2.3% 6(2.0) 8(5.7)
 20-24yrs 61(13.4) 44(10.0) 9.7% 27(9.0) 17(12.1)
 25-29yrs 96(21.1) 78(17.7) 21.5% 51(17.0) 27(19.3)
 30-34yrs 137(30.2) 141(32.0) 36.2% 95(31.7) 46(32.9)
 35-39yrs 104(22.9) 118(26.8) 24.8% 89(29.7) 29(20.7)
 ≥40yrs 44(9.7) 45(10.2) 5.5% 32(10.7) 13(9.3)
Note: Values are shown as n(%) unless otherwise stated. *Maternal age unknown for five mothers.
Table 1.4: Age distribution of mothers experiencing perinatal loss in 2011 and 2012
Ethnicity Perinatal deaths Perinatal deaths 15-49 year-old female 
 2011 2012 population, 2011
White Irish 331(72.6) 343(77.1) 80.4%
Irish Traveller 6(1.3) 16(3.6) 0.7%
Other white background 48(10.5) 49(11.0) 12.5%
Asian/Asian Irish 10(2.2) 16(3.6) 2.4%
Black/Black Irish 17(3.7) 12(2.7) 1.6%
Other/mixed 17(3.7) 6(1.3) 1.0%
Not recorded 27(5.9) 3(0.7) 1.4%
Note: Values are shown as n(%) unless otherwise stated. Population data from the National Census 2011
Table 1.5: Ethnicity of mothers experiencing perinatal loss in 2011 and 2012
11 Central Statistics Office. (2013) Vital Statistics Fourth Quarter and Yearly Summary 2012. Cork: CSO.
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Occupation
Lower socio-economic status has been 
shown to be associated with poor pregnancy 
outcomes.12 In the NPEC national clinical 
audit, data on the mother’s and father’s 
occupation at booking was sought. No data 
were recorded for 77 (17.3%) of the 445 
women who experienced perinatal loss. There 
were 181 (40.7%) cases with no data relating 
to the father’s occupation. Table 1.6 provides 
a high-level overview of the data that were 
provided on mother’s occupation alongside 
data available for the most comparable 
categories for mothers of all births from the 
Perinatal Statistics Report 201213 and for the 
15-44 year-old female population from the 
National Census 2011.
An occupation was specified for 71% of the 368 
mothers for whom data were recorded (Table 
1.6), which is the same as the proportion of all 
mothers in 2012 with a specified occupation. A 
limitation of this national audit and ESRI data is 
that occupation does not assess employment 
status. It can be seen that unemployed was 
recorded for 8% of the mothers experiencing 
perinatal loss compared to 5% of all mothers 
and 11% of the female population aged 15-44 
years. The proportion specified as engaged 
in home duties was similar for all women 
who gave birth in 2012 and for those who 
experienced perinatal loss and was higher 
than among the general population of women 
aged 15-44 years.
Occupation Perinatal deaths ESRI 15-44 year-old
 n(%) (%) female population
Occupation specified 260(70.7) 71.8 55.0%*
Unemployed 28(7.6) 4.5 10.5%
Home duties 68(18.5) 19.2 12.1%
Student 12(3.2) n/a 19.9%
Others not in labour force 0(0.0) n/a 2.5%
Note: Population data from Census 2011 relates to economic status rather than occupation, hence * represents the proportion 
at work.
Table 1.6: Occupation at booking of mothers experiencing perinatal loss, 2012
The NPEC Perinatal Death Notification Form 
records the highest level of education 
completed by the mother but this was not 
provided for the vast majority of the 445 
women (368, 82.7%). Level of education is not 
usually captured in maternity records but has 
been found to be associated with pregnancy 
outcome.14
12 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
13 Economic and Social Research Institute (ESRI). (2013) Perinatal Statistics Report 2012. Dublin: ESRI
14 Savitz, D.A.; Kaufman, J.S.; Dole, N.; Siega-Riz, A.M.; Thorp, J.M., Jr; Kaczor, D.T. Poverty, education, race, and pregnancy 
outcome. Ethn. Dis. 2004, 14, 322–329.
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Gestation at booking
Gestation at the time of the mother’s first 
antenatal visit to the maternity hospital was 
unrecorded for 15 stillbirths and 25 neonatal 
deaths. One in four booked into hospital before 
12 weeks gestation, almost two-thirds attended 
for antenatal care between 12 and 19 weeks 
gestation and approximately 10% attended at 20 
weeks gestation or later (Table 1.7). While most 
women attend a general practitioner in early 
pregnancy prior to their first visit at a maternity 
unit it can be seen that the proportion who 
booked into hospital after 20 weeks gestation 
halved from 25% in 2011 to 12% in 2012.
Gestation at Perinatal deaths Perinatal deaths Stillbirths Neonatal deaths
booking 2011 2012 2012 2012
Less than 12 Weeks 76 (18.9) 104(25.7) 75(26.0) 29(25.0)
12-19 Weeks 225(55.8) 253(62.5) 180(62.3) 73(62.9)
20 Weeks or Later 81(20.1) 43(10.6) 31(10.7) 12(10.3)
Not Booked 21(5.2) 5(1.2) 3(1.0) 2(1.7)
Table 1.7: Weeks gestation at date of first hospital booking in 2011 and 2012
Body mass index
Increased maternal BMI has been associated 
with an increased risk of congenital anomaly 
and stillbirth.15,16 The recording of BMI in 
maternity records is a key recommendation 
of the Obesity and Pregnancy Clinical Practice 
Guideline. While this may be common practice, 
no national data on the BMI of the pregnant 
population are available.
Body mass index (BMI) was available for 78.2% 
(n=348) of women who experienced perinatal 
loss in 2012 which is an improvement on the 
66.9% rate of recording for 2011. The BMI of 
almost half of those mothers (161, 46.3%) was 
in the healthy range (18.5-24.9kgm-2). One in 
three (33.3%; n=116) were classified as 
overweight (25.0-29.9kgm-2) and 20% (n=69) 
were obese (30.0-34.9kgm-2).  The proportion 
of mothers who were obese was lower in 2012 
than in 2011. The pattern of BMI in the mothers 
who experienced perinatal loss was similar to 
that in the women from the general population 
who participated in the 2007 Survey of 
Lifestyle, Attitudes and Nutrition (SLÁN).17 
There was some difference in the pattern of BMI 
between mothers who experienced stillbirth 
and those who experienced early neonatal 
death. Higher BMI was associated with those 
who experienced stillbirth (Overweight: 35.2% 
vs. 28.6%; Obese: 21.6% vs. 15.3%).
Table 1.8: Body mass index of mothers who experienced perinatal loss in 2011 and 2012
BMI Category (kgm-2) Perinatal deaths Perinatal deaths SLÁN
 2011 2012 2007
Underweight (<18.5) 4(1.3) 2(0.6) 2%
Healthy (18.5-24.9) 140(45.9) 161(46.3) 44%
Overweight (25.0-29.9) 83(27.2) 116(33.3) 31%
Obese (>30.0) 78(25.6) 69(19.8) 23%
Note: Values are shown as n(%) unless otherwise stated; SLÁN, Survey of Lifestyle, Attitudes and Nutrition
15 Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J 
Obstet Gynecol 2008;198:611-9
16 Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J 
Obstet Gynecol 2007;197:223-8.
17 Harrington J, Perry IJ, Lutomski J, Morgan K, McGee H, Shelley E, Watson D. (2008) Survey of Lifestyle, Attitudes and 
Nutrition in Ireland: Dietary Habits of the Irish Population. Dublin: The Stationery Office.
Note: Values are shown as n(%) unless otherwise stated.
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Smoking and substance abuse
Smoking status of the mothers at their time of 
booking was recorded for 412 (92.6%) of the 
445 women. Of these, 71 (17.2%) were smokers 
at the time, most (55.9%) smoking at least 10 
cigarettes per day. Information on smoking in 
late pregnancy was available for 48 of these 
mothers; only 5 (10.4%) stopped smoking 
during pregnancy.
 
The prevalence of smoking during pregnancy 
or in the last trimester is not routinely known 
for all Irish pregnancies but rates of 12%, 
15%, 16% and 19% have been reported for 
England, Northern Ireland, Wales and Scotland, 
respectively.18
There was one case with a documented 
history of alcohol abuse and five women had a 
documented history of drug abuse.
Previous pregnancy
Two thirds of the mothers had at least one 
previous pregnancy (301 of 445, 67.6%). In 
terms of parity, 42% were nulliparous which 
is marginally higher than for all births in 2012 
(Table 1.9). Women who experienced perinatal 
loss were more likely to be nulliparous or Para 
3+ compared to the general population of 
mothers delivered in 2012.
Parity Perinatal deaths Perinatal deaths All births 
 2011 2012 2012
Nulliparous 205(45.5) 186(41.8) 39.1%
Para 1 122(27.1) 129(29.0) 34.7%
Para 2 71(15.7) 72(16.2) 17.2%
Para 3+ 53(11.7) 58(13.0) 9.0%
Note: Values are shown as n(%) unless otherwise stated; Data for all births are from the ESRI’s Perinatal Statistics Report 201219
Table 1.9: Distribution of parity, 2011 and 2012
18 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
19 Economic and Social Research Institute (ESRI). (2013) Perinatal Statistics Report 2012. Dublin: ESRI
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Table 1.10 specifies gravida/parity for the 445 
women who experienced perinatal loss in 
2012. One in three (n=144, 32.4%) had never 
been pregnant before (gravida = 0). Of the 
301 women who had been pregnant (gravida 
> 0), approximately half (n=157, 52.2%) 
only had pregnancies ≥24 weeks (gravida 
= parity, indicated by pale green shading); 
one in three (n=102, 33.9%) experienced 
pregnancy ≥24 weeks and at least one 
pregnancy <24 weeks gestation and under 
500g birthweight (gravida > parity > 0, 
indicated by yellow shading); and, for 14% 
(n=42, 14.0%) their previous pregnancies 
never exceeded 24 weeks gestation or 500g 
birthweight (gravida > parity = 0, indicated 
by orange shading).
Table 1.10: Gravida/parity of mothers prior to experiencing perinatal loss in 2012
Note: We refer to gravida and parity prior to the pregnancy followed by perinatal death in 2012. Pale green represents women 
with previous pregnancies always ≥24 weeks; yellow represents women who had experienced pregnancy ≥24 weeks and 
pregnancy <24 weeks gestation and birthweight<500g; and, orange represents women whose previous pregnancies were 
always <24 weeks gestation and birthweight<500g
Gr
av
id
a
                          Parity 
 0 1 2 3 4 5 6 Total
0 144       144
1 28 86      114
2 9 33 42     84
3 2 7 17 16    42
4 1 3 7 11 10   32
5 0 0 3 4 8 1  16
6 1 0 2 1 3 0 2 9
7 0 0 0 0 1 1 0 2
8 0 0 1 0 0 0 0 1
9 1 0 0 0 0 0 0 1
Total 186 129 72 32 22 2 2 445
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Table 1.11: Previous pregnancy-related problems in 2011 and 2012
 2011 2012
 n(%) n(%) 
Previous caesarean delivery 55(18.9) 60(19.9)
Pre-eclampsia 18(6.2) 19(6.3)
Three or more miscarriages 19(6.5) 13(4.3)
Pre-term birth or mid-trimester loss 11(3.8) 13(4.3)
Stillbirth 5(1.7) 11(3.7)
Baby with congenital anomaly 7(2.4) 9(3.0)
Infant requiring intensive care 8(2.7) 6(2.0)
Post-partum haemorrhage requiring transfusion 5(1.7) 6(2.0)
Placental abruption 2(0.7) 4(1.3)
Neonatal death 7(2.4) 3(1.0)
Placenta praevia 1(0.3) 1(0.3)
Other 68(23.4) 54(17.9)
Note: Percentage of mothers who had a previous pregnancy
Pre-existing medical problems
Information about pre-existing medical 
problems was available for 423 of the 485 
mothers who experienced perinatal loss 
(95.1%). Forty percent of these 423 women 
had a pre-existing medical problem (169, 
40.0%). There were no highly prevalent 
conditions and no notable changes in the 
prevalence of specific problems from 2011 
to 2012 (Table 1.12). The Other category 
included a wide range of problems such as 
asthma, anaemia, infertility and urinary 
tract infection.
 2011 2012
 n(%) n(%) 
Hypertension 12(3.0) 22(5.2)
Endocrine disorder 19(4.7) 21(5.0)
Psychiatric disorder 23(5.7) 19(4.5)
Renal disease 7(1.7) 9(2.1)
Diabetes 7(1.7) 8(1.9)
Inflammatory disorder 7(1.7) 7(1.7)
Cardiac disease 8(2.0) 6(1.4)
Haematological disorder 7(1.7) 6(1.4)
Epilepsy 7(1.7) 5(1.2)
Other 126(31.3) 103(24.3)
Any pre-existing medical problem 179(44.5) 169(40.0)
Table 1.12: Pre-existing medical problems in mothers who experienced perinatal loss in 2011 and 2012
Almost half (n=133, 44.2%) of the 301 
mothers who had a previous pregnancy 
had had a pregnancy-related problem (Table 
1.11). One in five of the 301 mothers had a 
previous caesarean delivery, 6% had had 
pre-eclampsia. Three or more miscarriages, 
pre-term birth or mid-trimester loss and 
stillbirth were each experienced by 4% of the 
301 mothers who had a previous pregnancy.
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Delivery
Labour was induced in 63.5% of women who 
experienced a stillbirth and 10.6% of those who 
experienced a neonatal death. A caesarean 
section was the planned mode of delivery for 
8.9% (n=27) of the women who experienced a 
stillbirth and 12.9% (n=18) of the women who 
experienced an early neonatal death.
Almost all of the babies (n=433, 97.5%) were 
delivered under obstetric-led care which is 
the predominant model of care in Ireland. One 
baby (0.2%) was delivered under midwifery-
led care and ten babies (2.3%) were born 
before arrival at the maternity unit (five 
stillbirths and five early neonatal deaths).
Presentation at delivery, known for 422 of 
the 445 babies, was vertex presentation for 
three in four (n=316, 74.9%), almost one in 
four (n=96, 22.7%) was breech presentation 
and in ten cases the presentation was either 
compound (n=6), brow (n=1) or face (n=3).
Spontaneous vertex was the mode of delivery 
more often in cases of stillbirths (67.4%; Table 
1.13) than for all births in 2012. Respectively, 
40% and 43% of births with a subsequent 
early neonatal death were by spontaneous 
vertex delivery and caesarean section. Among 
stillbirths delivered by caesarean section, 
over 40% of the mothers (n=16, 42.1%) had 
had a previous caesarean delivery. Assisted 
breech deliveries were relatively common in 
cases of stillbirth (18.1%) and neonatal death 
(13.5%) whereas this was very rare for all 
births in 2012.
Table 1.13: Mode of delivery in mothers who experienced perinatal loss in 2012
Mode of delivery Stillbirths Neonatal deaths  All births, ESRI
 (N=304) (N=141) %
Spontaneous vertex delivery 205(67.4) 57(40.4) 55.6
Pre-labour caesarean section 31(10.2) 33(23.4) 28.8
Caesarean section after onset of labour 7(2.3) 27(19.1) 
Lift out forceps 2(0.7) 1(0.7) 3.9
Mid-cavity forceps 1(0.3) 1(0.7) 
Rotational forceps 2(0.7) - 
Assisted breech 55(18.1) 19(13.5) 0.4
Ventouse 1(0.3) 3(2.1) 11.2
Note: Values are shown in N (%) unless otherwise stated. Data for all births from the ESRI’s Perinatal Statistics Report 
201220
Most of the 98 deliveries by caesarean 
section were emergencies (n=57, 58.2%), 
16.3% were categorised as urgent (n=16) 
and one quarter were elective (n=24, 24.5%). 
The type of caesarean delivery differed by 
type of perinatal loss; caesarean deliveries 
with subsequent early neonatal death were 
more often emergencies (70% vs. 40% of 
stillbirths delivered by caesarean).
20 Economic and Social Research Institute (ESRI). (2013) Perinatal Statistics Report 2012. Dublin: ESRI
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Level of care for mothers post-delivery
The rate of admission to the high dependency 
unit (HDU) and the intensive care unit (ICU) 
was similar in 2011 and 2012 (Table 1.14). In 
2012, 29 mothers (6.5%) were admitted to the 
HDU following the delivery and seven mothers 
(1.6%) were admitted to the ICU. Admission to 
 
the HDU was more common in cases of early 
neonatal death than stillbirth. Higher rates of 
admission to both HDU (17.2%) and ICU (4.7%) 
were more likely following emergency pre-
labour caesarean section.
Infant characteristics
Sex
There were three perinatal deaths for which 
the sex of the baby was indeterminate. Of 
the 442 other perinatal deaths, just over half 
were male (n=224, 50.7%). This is in line with 
the overall population of births in 2012 in 
which 51.5% were male.21 Male babies slightly 
outnumbered female babies among early 
neonatal deaths but not among stillbirths 
(Table 1.15).
Multiple births
There was an association found in this audit 
between perinatal death and multiple pregnancies. 
There were 47 perinatal deaths from multiple births, 
making up 10.5% of all perinatal deaths in 2012. This 
is three times the proportion of multiples among all 
births in 2012 (3.5%). Consequently, the perinatal 
mortality rate of 18.6 per 1,000 multiple births was 
three times the national rate.20
The 47 perinatal deaths from multiple births 
comprised of 24 stillbirths and 23 early neonatal 
deaths. Half (n=12, 52.2%) of the 23 early neonatal 
deaths were due to respiratory disorders, usually 
severe pulmonary immaturity, generally associated 
with spontaneous premature labour or ascending 
infection. The main causes of the 24 stillbirths from 
multiple births were similar to those of all stillbirths 
in 2012, most commonly either major congenital 
anomaly or specific placental conditions. Based on 
the NPEC Maternal and Fetal Classification System, 
twin-twin transfusion was the main cause of death 
in six of the 47 deaths from multiple births (12.8%).
There were 32 cases where one twin died, seven 
cases where both twins died and one case where 
a triplet died. Chorionicity was reported for 45 of 
the 47 perinatal deaths from multiple births. Most 
were dichorionic diamniotic (n=26, 57.8%) and 
42.2% (n=19) were monochorionic diamniotic. 
The observed proportion of monochorionic 
diamniotic twins is higher than would be 
expected based on all twin deliveries in Ireland.
 Perinatal deaths Perinatal deaths Stillbirths Neonatal deaths
 2011 2012 2012 2012
Admitted to HDU 27(5.9) 29(6.5) 14(4.6) 15(10.6)
Admitted to ICU 8(1.8) 7(1.6) 5(1.6) 2(1.4)
 Stillbirths Early neonatal deaths
 n(%) n(%)
Male 148(48.7) 76(53.4)
Female 153(50.3) 65(46.1)
Indeterminate 3(1.0) -
Table 1.14: Post-delivery outcome for mothers who experienced perinatal loss in 2011 and 2012
Table 1.15: Sex of baby in stillbirths and neonatal deaths, 2012
21 Economic and Social Research Institute (ESRI). (2013) Perinatal Statistics Report 2012. Dublin: ESRI
Note: Values are n(%) unless otherwise stated.
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Gestation
Gestational age at delivery of 22-27 weeks 
was observed for one in three cases of early 
neonatal death compared to one in four 
stillbirths (Figure 1.4). Only 31% of stillbirths 
and one in four babies who died in their first 
week were not delivered pre-term.
Birthweight
The most represented birthweight in cases 
of perinatal death was in the range 500-999 
grams, especially for early neonatal deaths 
(Figure 1.5). For almost three quarters of 
perinatal deaths (70.4% of stillbirths and 
72.3% of neonatal deaths) the birthweight 
was less than 2,500 grams.
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Figure 1.5: Distribution of birthweight in stillbirths and neonatal deaths, 2012
Figure 1.4: Distribution of gestational age at delivery in stillbirths and neonatal deaths, 2012
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Figure 1.6: Optimal birthweight and normal range compared to actual birthweights of stillbirths, 2012
22 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
23 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
24 Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population–
based birthweight standards. BJOG 2001;108:830–4.
25 Royal College of Obstetrics and Gynaecologists. The investigation and management of the small-for-gestational age fetus. 
RCOG Green Top Guideline 2013 (NO.31). Available at: www.rcog.org.uk/files/rcog-corp/22.3.13GTG31SGA_ExecSum.pdf
Birthweight centile
An increased risk of perinatal death has been 
associated with failure of fetal growth in utero. We 
have produced two charts to highlight this issue 
in relation to the stillbirths and early neonatal 
deaths that occurred in Ireland in 2012. To do so, 
we used the Gestation Related Optimal Weight 
(GROW) software22 and coefficients derived from 
the multiple regression analysis of data on 11,072 
births in six maternity units in Dublin, Galway, 
Limerick and Belfast in 2008-2009.23
The regression analysis determined the Term (i.e. 
40 weeks) Optimal Weight (TOW) in Ireland to be 
3,490.7g. The normal range (i.e. the range from 
the 10th centile weight to the 90th centile weight) 
around the TOW was then calculated and the 
recommended proportionality growth function was 
applied to the TOW, the 10th centile term weight and 
the 90th centile term weight in order to determine 
the optimal weight and normal range at all 
gestations (21-44 weeks for the stillbirths and early 
neonatal deaths in Ireland in 2012). These steps are 
described in detail in the GROW documentation.
The optimal weight and normal range for all 
gestations are plotted with the actual birthweights 
of the stillbirths in Figure 1.6 and with the 
birthweights for the cases of early neonatal death 
in Figure 1.7. For the stillbirths, it can be seen that 
the majority were below the lower limit of the 
normal range (10th centile). This was particularly 
associated with stillbirths occurring between 24-
37 weeks gestation. In cases of early neonatal 
death, the birthweight was often below the normal 
range, particularly for births after 33 weeks 
gestation. However, this was observed less often 
than for cases of stillbirth.
Figures 1.6 and 1.7 have the limitation of plotting 
actual birthweights against the optimal weight 
and normal range adjusted only for gestational 
age. There is no adjustment for other factors 
affecting birthweight; namely, maternal height, 
weight, parity and ethnic group and infant sex. The 
use of centiles customised for maternal and infant 
characteristics affecting birthweight identifies 
small babies at higher risk of mortality better 
than population centiles.24 Small-for-gestational-
age (SGA) refers to birthweights below the 10th 
centile and severely SGA refers to birthweights 
less than the 3rd centile. 25
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Figure 1.7: Optimal birthweight and normal range compared to actual birthweights in cases of early neonatal death, 2012
Figure 1.8: Distribution of customised birthweight centiles for stillbirths, 2012
Customised birthweight centiles were derived 
using the GROW software.26 There was a high 
level of missing data for maternal height and 
weight with one or both unknown for over 40% 
of the mothers (n=195, 42.8%). For these 
cases, we used the median height and weight 
of the mothers with complete data. As a 
result, it was possible to calculate customised 
birthweight centiles for almost all of the 456 
mothers (n=442, 96.9%).
The distribution of customised birthweight 
centiles at all gestations is illustrated for 
stillbirths in Figure 1.8 and for cases of early 
neonatal death in Figure 1.9. At all gestations, 
there were cases spanning the full range of 
birthweight centiles (i.e. 0-100th) but there 
was a clear overrepresentation of cases below 
the median and far more at or near centile 
zero than would be expected in the population 
of all births.
26 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
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Figure 1.9: Distribution of customised birthweight centiles for early neonatal deaths, 2012
Table 1.16 details the number and percentage 
of stillbirths and early neonatal deaths within 
specific ranges of customised birthweight 
centiles. Low birthweight was associated with 
both groups but particularly with stillbirths. 
Almost one in three (30.2%) had a birthweight at 
centile zero compared to 19.3% of early neonatal 
death cases. Just over 40% of stillbirths were 
classified as severely SGA and over half were 
SGA (54.0%) compared to 24.3% and 40.0% of the 
cases of early neonatal death, respectively.
SGA may be more prevalent among stillborn 
babies because they may have died some 
days or weeks before being delivered. We do 
not record whether there was evidence of 
maceration in cases of stillbirth but there was 
support for this hypothesis. The data showed a 
correlation whereby the longer the time between 
confirmation of death and time of delivery, the 
lower the customised birthweight centile of the 
stillborn baby.
Centile Stillbirth n(%) Neonatal death n(%)
 (N=298) (N=140)
Zero 90(30.2) 27(19.3)
< 3rd 124(41.6) 34(24.3)
< 10th 161(54.0) 56(40.0)
10-49th 83(27.9) 49(35.0)
50-89th 38(12.8) 25(17.9)
90th+ 16(5.4) 10(7.1)
Note: Centiles could not be calculated for six stillbirths and one early neonatal death
Table 1.16: Distribution of customised birthweight centiles, 2012
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The NPEC Perinatal Death Notification Form 
contains a specific question on whether a 
diagnosis of IUGR was made in perinatal deaths 
and the timing of diagnosis if applicable. A 
diagnosis of IUGR was reported for 68 (15.3%) 
of the 445 perinatal deaths (unknown for 
two cases) - 17.2% of stillbirths (n=52) and 
11.4% of early neonatal deaths (n=16). In 
most diagnosed cases, IUGR was suspected 
 
antenatally (Table 1.18). More than 80% of the 
cases with a diagnosis of IUGR (n=57 of 68, 83.8%) 
were severely SGA (<3rd customised birthweight 
centile). Where a diagnosis of IUGR was made, 
major congenital anomaly was the main cause of 
death in half the cases (n=32, 47.1%), placental 
conditions were the main cause of death in one in 
four cases (n=16, 23.5%) and IUGR was the main 
cause of death for seven cases (10.3%).
Among the 410 mothers whose smoking status 
was known at the time of their hospital booking, 
there was little difference in the prevalence 
of diagnosed IUGR in the infants of smokers 
(n=14 of 70, 20.0%) and non-smokers (n=52 of 
340, 15.3%). A diagnosis of IUGR was relatively 
common among mothers with a pregnancy-
related hypertensive disorder (n=10 of 26, 
38.5% versus n=58 of 417 mothers without 
pregnancy-related hypertension, 13.9%).
An invited commentary on fetal growth 
restriction and the risk of perinatal death 
follows this section of the Report.
Centile Stillbirth Neonatal death
 (N=298) (N=140)
 Cause of death: major congenital anomaly Cause of death: major congenital anomaly
 Yes (n=78) No (n=220) Yes (n=68) No (n=72)
Zero 39(50.0%) 51(23.2%) 21(30.9%) 6(8.3%)
< 3rd 46(59.0%) 78(35.5%) 27(39.7%) 7(9.7%)
< 10th 51(65.4%) 110(50.0%) 38(55.9%) 18(25.0%)
10-49th 14(17.9%) 69(31.4%) 17(25.0%) 32(44.4%)
50-89th 6(7.7%) 32(14.5%) 7(10.3%) 18(25.0%)
90th+ 7(9.0%) 9(4.1%) 6(8.8%) 4(5.6%)
Note: Centiles could not be calculated for six stillbirths and one early neonatal death
Table 1.17: Distribution of customised birthweight centiles of perinatal deaths due and not due to major 
congenital anomaly, 2012
 Stillbirth n(%) Neonatal death n(%)
 (N=52) (N=16)
Suspected antenatally 32(61.5) 13(81.3)
Observed at delivery 27(51.9) 7(43.8)
Observed at post-mortem 19(36.5) 4(25.0)
Note: Categories are not mutually exclusive and may add up to more than 100%
Table 1.18: Diagnosis of intra-uterine growth restriction, 2012
Cases of stillbirth and early neonatal death 
were at significantly lower birthweight centiles 
when the cause of death was attributed to 
major congenital anomaly (Table 1.17). Most 
of the 78 stillbirths due to congenital anomaly 
(n=46, 59.0%) were severely SGA (<3rd 
customised birthweight centile) whereas this 
was the case for one third of the stillbirths 
due to other causes (n=78, 35.5%). Similarly, 
40% of the 68 early neonatal deaths due 
to congenital anomaly (n=27, 39.7%) were 
severely SGA compared to 10% (n=7, 9.7%) 
of the 72 early neonatal deaths due to other 
causes.
Diagnosis of intra-uterine growth restriction (IUGR)
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Autopsy
Current practice guidelines27 recommend that 
parents should be offered a full post-mortem 
examination of the stillborn infant to help 
explain the cause of death. Data on autopsy 
uptake was reported for 442 of the 445 perinatal 
deaths of which 45.2% (n=200) underwent 
an autopsy. This is higher than in 2011 when 
40.7% of perinatal deaths had an autopsy 
performed. Variation in the perinatal autopsy 
rate from year to year is more pronounced for 
early neonatal deaths (Figure 1.10). The rate 
of autopsy in stillbirths has shown a gradual 
decline since 2008 but is always higher than 
the rate for early neonatal deaths. In 2012, an 
autopsy was undertaken following 47.7% of 
stillbirths and 39.0% of early neonatal deaths. It 
has been reported that in Scotland in 2012, the 
autopsy rate was 57.7% for stillbirths and 34.5% 
for neonatal deaths.28
There was significant variation in the rate of 
autopsy across the 20 maternity units in 2012, 
from 9.1% to 66.7%, as illustrated in Figure 1.11. 
Most of this variation was observed across the 
smaller maternity units as the autopsy rate for 
the four large maternity units was 48.9-61.1%. 
This may be expected given the smaller numbers 
involved but it may also reflect variation in 
access to dedicated perinatal pathology services 
for smaller units.
Figure 1.10: Autopsy uptake rate, 2008-2012
27 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute 
of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
28 Healthcare Improvement Scotland. (2014) Scottish Perinatal and Infant Mortality and Morbidity Report 2012. Edinburgh: NHS 
National Services Scotland.
Investigations to determine the cause of death
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Figure 1.12 details the autopsy-related steps 
taken following the 445 perinatal deaths in 2012. 
Thirty-one (7.0%) of the deaths became coroner 
cases. These cases underwent autopsy and at 
the time data were reported to the NPEC, the 
maternity unit had received the autopsy report 
from the coroner’s office in 26 of the 31 cases. 
There were 169 autopsies undertaken following 
the 414 deaths that were not coroner cases, an 
autopsy rate of 40.8% (136, 46.1% for stillbirths 
and 33, 27.7% for early neonatal deaths).
There were 242 perinatal deaths that did 
not receive an autopsy. For the majority 
an autopsy was offered and presumably 
declined by parents (n=184, 78.0%, unknown 
for six cases). Such an offer was made 
more often in cases of stillbirth (128 of 157, 
81.5%, unknown for two cases) than for early 
neonatal deaths (56 of 79, 70.9%, unknown 
for four cases). Consequently, there were 52 
deaths for which an autopsy was not offered, 
constituting 11.7% of all perinatal deaths.
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Figure 1.11: Autopsy uptake in the 20 Irish maternity units in 2012
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Figure 1.12: Flowchart describing autopsy-related steps taken after 445 perinatal deaths in 2012
Note: Autopsy unknown for three cases of early neonatal death. Autopsy offer unknown for two cases of stillbirth and four 
cases of early neonatal death.
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The decision not to offer to undertake an 
autopsy may be influenced by the clinical 
scenario and the antenatal diagnosis. There 
was evidence to support this in relation to 
major congenital anomaly. The proportion of 
cases not offered an autopsy was higher if the 
perinatal death was due to a major congenital 
anomaly than if it the death was due to 
another cause (Table 1.19).
Autopsy Stillbirth (N=302) Neonatal death (N=134)
 Cause of death: major congenital anomaly Cause of death: major congenital anomaly
 Yes (n=79)* No (n=223) Yes (n=63)* No (n=71)
Performed 34(43.0%) 111(49.8%) 24(38.1%) 31(43.7%)
Offered 30(38.0%) 98(43.9%) 24(38.1%) 32(45.1%)
Not offered 15(19.0%) 14(6.3%) 15(23.8%) 8(11.3%)
*Note: Autopsy unknown for three cases of early neonatal death. Autopsy offer unknown for two cases of stillbirth and four cases of early neonatal death.
Table 1.19: Uptake and offer of autopsy of perinatal deaths due and not due to major congenital anomaly, 2012
Placental examination
The value of placental examination in 
determining cause of perinatal death is well 
documented.29 In 2012, placental histology 
examinations were conducted for almost all 
stillbirths (n=293, 96.4%) and for 80.1% of early 
neonatal deaths (n=113). This is higher than in 
2011 when placental histology was performed 
in 93% of stillbirths and 69% of neonatal deaths.
29 Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed 
diagnostic workup. Am J Obstet Gynecol 2012 206:53.e1-53.e12
Specific placental conditions
Specific placental conditions were diagnosed 
in 282 (62.9%) of the 448 perinatal deaths 
(unknown for one neonatal death). A specific 
placental condition was reported in almost two 
thirds of stillbirths (n=198, 65.1%) and neonatal 
deaths (n=84, 60.0%). Specific placental 
conditions were more frequent for stillbirths 
than for neonatal deaths with the exception of 
chorioamnionitis which was reported in 14.3% 
of early neonatal deaths compared to 8.9% of 
stillbirths. Severity of chorioamnionitis was 
reported for 41 of the 47 cases. The vast majority 
were either moderate (n=15, 36.6%) or severe 
(n=18, 43.9%). Placental infarction was the 
most frequently reported placental condition for 
stillbirths (10.5%) and was considerably more 
common than in early neonatal deaths (0.7%). 
Almost half of stillbirths (42.8%) and almost one 
third (29.3%) of early neonatal deaths reported 
other placental conditions.
 Stillbirth n(%) Neonatal death n(%)
 (N=304) (N=140)
Vasa praevia 2(0.7) 0(0)
Velamentous insertion 9(3.0) 0(0)
Massive perivillous fibrin deposition 2(0.7) 0(0)
Placental infarction 32(10.5) 1(0.7)
Chorioamnionitis 27(8.9) 20(14.3)
Fetal vasculitis 9(3.0) 3(2.1)
Retroplacental haemorrhage 28(9.2) 5(3.6)
Thrombosis in fetal circulation 23(7.6) 2(1.4)
Villitis 8(2.6) 4(2.9)
Other 130(42.8) 41(29.3)
Any placental condition 198(65.1%) 84(60.0%)
Note: Data were unknown for one neonatal death
Table 1.20: Specific placental conditions for stillbirths and neonates, 2012
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Procedure Stillbirth n(%) Neonatal death n(%)
 (N=304) (N=141)
External examination 114(37.5) 56(39.7)
X-Ray 45(15.1) 18(12.8)
CT scan 1(0.3) 1(1.4)
MRI 2(0.7) 2(1.4)
Table 1.21: Other examinations performed in investigating perinatal deaths in 2012
The prevalence rates reported for some 
specific placental conditions in Table 
1.20 are lower than those reported in 
previous studies.30,31 Whether this reflects 
varying degrees of detection, reporting or 
interpretation of placental histology reports 
warrants further investigation.
Other examinations performed
External examination was made for almost 40% 
of all cases of perinatal death (Table 1.21). X-Ray 
was performed for 15.1% of stillbirths and 12.8% 
of neonatal deaths.
Cytogenetic analysis is an important 
investigation in the diagnosis of chromosomal 
abnormalities.32 Some abnormalities are 
potentially recurrent and can be tested for 
in future pregnancies.   In the event of a 
chromosomal disorder, a specific question 
on the NPEC Perinatal Death Notification 
form asks how the diagnosis was made. A 
major congenital chromosomal disorder was 
the main cause of 38 stillbirths and 17 early 
neonatal deaths. For three quarters of these 
cases, the diagnosis was made by cytogenetic 
analysis (n=28 of 38 stillbirths, 73.7%; n=13 
of 17 neonatal deaths, 76.5%).
30 Beebe LA, Cowan LD, Altshuler G. The epidemiology of placental features: Associations with gestational age and neonatal 
outcome. Obstetrics & Gynecology. 87(5):771-778, 1996.
31  Mooney EE. Implantation and placenta; and Mooney EE, Doyle EM. Non-neoplastic maternal gestational diseases (2014). In: 
Mutter GL, Prat J, eds. Pathology of the Female Reproductive Tract. 3rd edition. London: Churchill Livingstone. ISBN 9780702044977
32 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute 
of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
Cytogenetic investigation in chromosomal disorders
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Fetal growth restriction (FGR) is an important 
and common complication of pregnancy that is 
associated with increased perinatal morbidity 
and mortality.33,34 It is estimated that FGR 
affects up to 10% of pregnancies. In addition 
to congenital malformations and infectious 
causes, FGR has been identified as a major 
contributor to perinatal mortality.35,36
Perinatal deaths commonly occur in women 
with coexistent maternal co-morbidities or 
who have a history of adverse pregnancy 
outcomes, such as recurrent pregnancy 
loss, stillbirth or neonatal death.37 In addition, 
ethnic minorities are an overrepresented 
group among women who experience perinatal 
deaths.38,39 The perinatal outcome of FGR 
fetuses is largely dependent on the severity 
of growth restriction with those below the 3rd 
centile and/ or with abnormal umbilical artery 
(UA) Doppler measurements at greatest risk of 
adverse outcome.40,41 Other important prenatal 
determinants of perinatal outcome are 
gestational age at delivery and birthweight.42
Definition, Diagnosis and Management of FGR
There is no international consensus as to which 
clinical and sonographic parameters are the most 
appropriate to define intrauterine growth failure. The 
traditional cut-off used to define FGR, a term often 
interchangeably used with small-for-gestational 
age (SGA) or intrauterine growth restriction (IUGR), 
is an abdominal circumference (AC) or estimated 
fetal weight (EFW) below the 10th centile plotted 
against population43 or customised44 growth 
standards. The 10th centile has been suggested as 
a cut-off, given that at this level the risk of perinatal 
morbidity and mortality increases. At this arbitrary 
cut-off however the distinction between normal 
and pathologic growth often cannot reliably be 
made in the antenatal setting, and approximately 
50-70% will be constitutionally healthy small 
infants not at risk of adverse perinatal outcome.45,46 
In contrast, some infants born above the 10th 
centile, who might have been destined, for example, 
to be on the 80th centile, will be growth restricted. 
Unsurprisingly, the inconsistencies in FGR 
definition and diagnosis lead to further 
uncertainties regarding the optimal antenatal 
surveillance and management of affected 
pregnancies. Unfortunately, there is very little 
evidence from randomised controlled trials to 
inform best practice for antenatal surveillance 
regimens in FGR. In order to improve and 
standardise the care of pregnancies affected by 
FGR, a clinical practice guideline applicable for the 
Irish maternity setting was recently published.47
2. Invited commentary: Fetal growth restriction and 
the risk of perinatal mortality
33 Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont 
Oxford Network. Am J Obstet Gynecol 2000;182(1 Pt 1):198-206.
34 Baschat AA, Cosmi E, Bilardo CM, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007;109(2 Pt 1):253-261.
35 Manning E, Corcoran P, Meaney S, Greene RA, on behalf of the Perinatal Mortality Group. Perinatal Mortality in Ireland, Annual Report 2011. Cork: National Perinatal 
Epidemiology Centre. 2013.
36 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 2013;346:f108.
37 Frias AE, Jr., Luikenaar RA, Sullivan AE, et al. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104(3):521-526.
38 Unterscheider J, O’Donoghue K, Daly S, et al. Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study. BMC Pregnancy 
Childbirth 2014;14:63.
39 de Graaf JP, Steegers EA, Bonsel GJ. Inequalities in perinatal and maternal health. Curr Opin Obstet Gynecol 2013;25(2):98-108.
40 Lees C, Marlow N, Arabin B, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal 
flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013;42(4):400-408.
41 Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol 
2013;208(4):290 e291-296.
42 Baschat AA, Cosmi E, Bilardo CM, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007;109(2 Pt 1):253-261.
43 Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study. Am J Obstet 
Gynecol 1985;151(3):333-337.
44 Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customised antenatal growth charts. Lancet 1992;339(8788):283-287.
45 Lees C, Marlow N, Arabin B, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow 
in Europe (TRUFFLE). Ultrasound Obstet Gynecol 2013;42(4):400-408.
46 Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. Am J Obstet Gynecol 
2013;208(4):290 e291-296.
47 Clinical Practice Guideline No 29 (2014). Fetal Growth Restriction – Recognition, Diagnosis and Management: Institute of Obstetricians and Gynaecologists, Royal College 
of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
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FGR and Perinatal Mortality
Advances in obstetrical and critical neonatal 
care are reflected in a substantial decrease in 
the overall perinatal mortality rate (PNMR) in 
high income countries.48 While this effect is 
mainly seen in a reduction of early neonatal 
deaths, stillbirth rates have remained largely 
unchanged over the past years.49,50 Stillbirth 
affects 1 in 200 pregnancies; as outlined in 
this report there were 71,755 births and 445 
perinatal deaths in 2012. Similar to the previous 
NPEC perinatal mortality report,51 stillbirths 
and early neonatal deaths accounted for 68% 
(n=304) and 32% (n=141) of perinatal deaths 
respectively, corresponding to a PMR of 6.2/ 
1,000 births. Of the 445 perinatal deaths, a 
third (n=148) were attributed to congenital 
structural or genetic abnormalities (corrected 
PMR 4.1/ 1,000). Half of infants affected 
by perinatal deaths in 2012 were identified 
as having birthweights below the 10th 
customised centile.
As outlined in Figure 2.1, whether or not FGR 
is identified prenatally influences the risk 
of stillbirth. While the risk of stillbirth (SB) 
in pregnancies with prenatally identified 
FGR is 1% (9.7/ 1,000 births), pregnancies 
with unrecognised FGR carry an over 8-fold 
increased risk of SB when compared to 
pregnancies without FGR (19.8 versus 2.4/ 
1,000 births).52 Some studies state that FGR 
may be overestimated as attributing factor in 
perinatal mortality cases due to intrauterine 
retention following intrauterine demise and 
the effect of maceration.53
Figure 2.1: Stillbirth rates for pregnancies overall and for pregnancies with detected and 
undetected FGR (from Gardosi J)54
48 Flenady V, Middleton P, Smith GC, et al. Stillbirths: the way forward in high-income countries. Lancet 2011;377(9778):1703-1717.
49 Lawn JE, Blencowe H, Pattinson R, et al. Stillbirths: Where? When? Why? How to make the data count? Lancet 2011;377(9775):1448-
1463
50 Cousens S, Blencowe H, Stanton C, et al. National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: 
a systematic analysis. Lancet 2011;377(9774):1319-1330.
51 Manning E, Corcoran P, Meaney S, Greene RA, on behalf of the Perinatal Mortality Group. Perinatal Mortality in Ireland, Annual Report 
2011. Cork: National Perinatal Epidemiology Centre. 2013.
52 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 
2013;346:f108.
53 Maroun LL, Graem N. Autopsy standards of body parameters and fresh organ weights in nonmacerated and macerated human fetuses. 
Pediatr Dev Pathol 2005;8(2):204-217.
54 Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and fetal risk factors for stillbirth: population based study. BMJ 
2013;346:f108.
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55 McCowan LM, Roberts CT, Dekker GA, et al. Risk factors for small-for-gestational-age infants by customised birthweight 
centiles: data from an international prospective cohort study. BJOG 2010;117(13):1599-1607.
56 Chauhan SP, Beydoun H, Chang E, et al. Prenatal Detection of Fetal Growth Restriction in Newborns Classified as Small for 
Gestational Age: Correlates and Risk of Neonatal Morbidity. Am J Perinat 2014;31(3):187-94.
57 Clinical Practice Guideline No 29 (2014). Fetal Growth Restriction – Recognition, Diagnosis and Management: Institute of 
Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
Improving the Antenatal Detection of FGR
One of the core problems in FGR is the 
poor detection rate in pregnancies that are 
at subsequent risk of adverse outcome, 
in particular stillbirth. Current antenatal 
detection rates of FGR are reported to be as 
low as 25 to 36%.55,56 Therefore, a preventative 
strategy to reduce stillbirths is to improve the 
antenatal detection of fetal growth failure. 
Whenever FGR is diagnosed prenatally, 
increased surveillance and timely delivery 
aims to improve perinatal outcome in FGR, 
balancing the risk of antepartum stillbirth by 
remaining in utero and iatrogenic prematurity 
potentially causing significant morbidity or 
neonatal death by too early intervention. 
Figure 2.2 illustrates an algorithm for the 
management of fetal growth restriction as 
recommended in the national clinical practice 
guideline.57
 
 
Clinical suspicion/ risk factors 
 
Sonographic assessment of 
fetal weight (EFW Hadlock-4) 
 
EFW <10th centile 
 Ensure accurate dating 
Consider deriving a customised centile 
Assess anatomy/ placenta/ amniotic fluid volume 
Perform UA Doppler 
 
 
EFW >10th centile 
 
Routine care, consider follow up scan in 4 weeks 
UA Doppler (PI >95th, +EDF) 
  Repeat sonogram in 2-weekly 
intervals  
 Assess biometry,  UA and AFI 
 Consider delivery at 37 weeks and 
no later than 40 weeks if good 
interval growth 
 
Normal UA 
 
UA REDF* 
 
UA AEDF* 
  Repeat sonogram in weekly intervals 
or more frequently as necessary  
 Assess UA, AFI; (MCA optional) 
 2-weekly biometry assessment 
 Timed corticosteroids < 34 weeks 
 Consider delivery at 37 weeks, or 
earlier if poor interval growth 
 Admit, repeat sonogram in twice 
weekly intervals or more frequently 
as necessary  
 Assess UA, AFI; (MCA optional) 
 Timed corticosteroids 
 Deliver no later than 34 weeks 
 MgSO4 <32 weeks 
 
 Admit, repeat sonogram in thrice 
weekly intervals or more frequently 
as necessary 
 Assess UA, AFI; (MCA optional) 
 Timed corticosteroids 
 Deliver no later than 30 weeks 
 MgSO4 <32 weeks 
 
In all cases, delivery is also indicated by abnormal CTG, ideally based on short term variation CTG if fetus deemed viable (ie GA >24 weeks and EFW >500grams) 
*In cases of AREDF, consider the opinion of a fetal medicine specialist regarding timing of delivery 
 
Algorithm – Management of Fetal Growth Restriction 
Send placenta for histopathology 
Obtain arterial and venous cord pH  
 
Review of placental histology 
Consider thrombophilia screening 
Modification of risk factors 
Prevention with Aspirin/ LMWH 
 
Offer follow up appointment to women with IUGR <3rd centile and delivery <34 weeks 
 
ABBREVIATIONS: EFW, estimated fetal weight (Hadlock-4); UA, umbilical artery; EDF, end-diastolic flow; AEDF, absent end-diastolic flow; REDF, reversed end-diastolic flow; AFI, amniotic fluid index; AREDF, absent or 
reversed end-diastolic flow in UA; CTG, cardiotocograph; MCA; middle cerebral artery; GA, gestational age, LMWH, low molecular weight heparin. 
Figure 2.2: Algorithm for management of fetal growth restriction
40  PERINATAL MORTALIT Y IN IREL AND ANNUAL REPORT 2012 
58 Gardosi J, Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. BJOG 
1999;106(4):309-317.
59 Sovia U, Smith G, Dacey A. Level 1 evidence for the diagnostic effectiveness  of routine sonography as a screening test for 
small for gestational age (SGA) infants. Am J Obstet Gynecol 2014;210(1):S408.
60 Barker ED, McAuliffe FM, Alderdice F, et al. The role of growth trajectories in classifying fetal growth restriction. Obstet 
Gynecol 2013;122(2 Pt 1):248-254.
Abdominal palpation and fundal height 
measurement are imprecise in screening for 
fetal growth aberrations; they are, however, 
the only physical examination methods 
available. In current practice a scan for fetal 
biometry is only performed when clinical 
concerns over fetal size are raised, and in the 
presence of significant maternal risk factors 
or prior pregnancy complications.
In an effort to improve the antenatal detection 
of FGR in a maternity care system which does 
not provide serial ultrasound scanning for all 
pregnancies, Gardosi et al58 have formulated 
customised fundal height charts which 
take into account physiological maternal 
variables. Another recent study focused 
on improving the prenatal detection by the 
provision of routine ultrasound scans at 28 
and 36 weeks’ gestation; a research group 
at Cambridge University recently presented 
level 1 evidence of diagnostic effectiveness 
that this approach performs well as a 
screening test to detect FGR in a population 
of unselected nulliparous women.59
A care model whereby every pregnant patient 
receives an ultrasound scan at least 4 weekly 
intervals would improve identification of 
growth failure based on population and 
customised growth standards. Given that 
FGR can also occur in infants born with 
birthweights above the 10th centile cut-
off, this approach would also allow us to 
comment on growth trajectories which have 
been identified as an important factor in 
the prediction of morbidity and mortality 
outcomes.60 The relevance to clinical practice 
in reducing perinatal morbidity and mortality 
could be the subject of future research studies 
comparing various models of antenatal care. 
This will impact on resource issues, increase 
obstetric intervention but no doubt will have 
an impact on the antenatal detection and 
reduction in perinatal deaths.
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3. Stillbirths: Specific findings
Figure 3.1: Primary cause of death in stillbirths (left-hand chart) and detailed cause in cases of major congenital 
anomaly (right-hand chart)
Cause of death in stillbirths
Major congenital anomaly was the primary 
cause of death in one quarter (n=80, 26.3%) 
of the 304 stillbirths occurring in 2012 (Figure 
3.1). There was a chromosomal disorder in 
half of the 80 stillbirths (n=38, 47.5%) due to 
congenital anomaly. In these cases, the majority 
were diagnosed by cytogenetic analysis (n=28, 
73.7%). Anomalies of the central nervous system 
and multiple anomalies caused a further 11 
(13.8%) and 10 (12.5%) stillbirths, respectively.
Specific placental conditions were diagnosed in two-
thirds (65.1%) of stillbirth cases and in one in four 
stillbirth cases (n=73, 24.0%), the specific placental 
condition was classified as the main cause of death. 
Half of these 73 cases were due to either placental 
insufficiency (n=17), placental infarction (n=12) or 
fetal thrombotic vasculopathy (n=8). There were 25 
stillbirths due to mechanical factors, all but one of 
which were due to the umbilical cord being around 
the baby’s neck or another entanglement or knot 
in the umbilical cord. Antepartum or intrapartum 
haemorrhage was the main cause of death in 21 
cases of stillbirth and placental abruption was 
involved in all of these cases. For the 16 stillbirths 
with infection as the main cause of death, most 
involved chorioamnionitis (n=11).
There were 69 stillbirths (22.7%) for which 
the cause of death was unexplained which is 
significantly lower than the proportion previously 
reported as unexplained using the Wigglesworth 
Classification System. For most of the stillbirths 
of unexplained cause (n=38, 55.1%), antecedents 
or associated obstetric factors were present but 
did not cause the death. In 30 cases (43.4%), it 
was reported that there were no antecedents or 
associated obstetric factors. For most of these 30 
cases (n=20, 66.7%) an autopsy was offered but 
not performed. A detailed listing of the main cause 
of death for the 304 stillbirths is given at the end 
of this section of the report.
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Factors influencing the delivery management 
of women experiencing antepartum 
stillbirths include maternal choice, maternal 
wellbeing, risk of developing severe medical 
complications and previous obstetric 
history. Management of clinical care may 
involve planned induction of labour, awaiting 
spontaneous labour or in some cases elective 
delivery by caesarean section.61
In 2012, labour was induced for two-thirds 
of the 278 women experiencing antepartum 
stillbirth (n=184; 66.2%) whereas labour was 
spontaneous for 23.0% (n=64). It can be seen 
from Figure 3.2 that the time from diagnosis 
of fetal demise to delivery was different for 
women whose labour was induced than it was 
for women whose labour was spontaneous. 
The confirmation of death and delivery took 
place on the same day for half of the women 
whose labour was spontaneous. For women 
whose labour was induced, it was common for 
one to three days to pass between diagnosis 
and delivery.
? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
Figure 3.2: Time from confirmation of fetal demise to stillbirth delivery for women with induced and spontaneous labour
61 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
Management of women experiencing antepartum stillbirths
Vaginal birth is the recommended mode 
of delivery for most women experiencing 
antepartum stillbirth, but caesarean section 
may be clinically indicated in some cases.61 
Spontaneous vertex delivery was the mode of 
delivery in more than two-thirds of cases of 
antepartum stillbirth (69.4%) compared to three 
of the 15 cases of intrapartum stillbirth (20.0%).
In 27 cases of antepartum stillbirth (9.7%), 
the intended mode of delivery was a planned 
caesarean section and ultimately, caesarean 
section was the mode of delivery for 37 women 
(including 31 pre-labour caesarean sections and 
six caesarean sections performed after onset of 
labour).
Of the 37 women who were delivered by 
caesarean section, the indication for caesarean 
section was classified as an ‘emergency’ in 
almost 40% of the cases, 13.5% were classified 
as ‘urgent’ and almost half were classified as 
‘elective’ (Table 3.1). Fifteen (40.5%) of the 37 
women had a caesarean section previously, one 
in four (n=10, 27.0%) had a multiple delivery 
and seven (18.9%) had a placental abruption, all 
factors that may have influenced the mode of 
delivery.
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Indication for caesarean section n(%)
Elective: At a time to suit the woman or the maternity team 18(48.6)
Urgent: Maternal or fetal compromise which is not immediately life threatening 5(13.5)
Emergency: Immediate threat to life of woman or baby 14(37.8)
Table 3.1: Indication for caesarean section in women experiencing antenatal stillbirth in 2012
62 Darmstadt G, Yakoob M, Haws R, Menezes E, Soomro T and Bhutta Z. Reducing stillbirths: interventions during labour. BMC 
Pregnancy and Childbirth 2009;9 (Suppl 1):s6
63 Healthcare Improvement Scotland. (2014) Scottish Perinatal and Infant Mortality and Morbidity Report 2012. Edinburgh: 
NHS National Services Scotland.
The location of delivery of antepartum 
stillbirths in all but two cases (n=276, 99.3%) 
was in obstetric-led maternity units. The two 
exceptions were born before arrival to hospital.
Of the 15 intrapartum deaths, six (40.0%) 
were due to major congenital anomaly and six 
(40.0%) were due to chorioamnionitis or other 
ascending infection. Intra-uterine growth 
restriction and associated obstetric factors 
accounted for a further two cases. In only 
one case was the cause of death classified 
as unexplained. There was no clustering by 
hospital in the intrapartum deaths due to 
causes other than congenital anomaly. It 
was reported that a local hospital review was 
undertaken into half of the intrapartum deaths 
(7 of 13, 53.8%, unknown in two cases).
Intrapartum stillbirths
It has been suggested that the comparatively 
low proportion of intrapartum stillbirths in 
high-income countries indicates that fetal 
deaths occurring in labour, in non-anomalous 
babies, are most likely preventable with quality 
intrapartum care.62 Intrapartum deaths in this 
audit were identified by a specific question on 
the NPEC Perinatal Death Notification Form as to 
whether the baby was alive at the onset of care 
in labour. Thus, intrapartum deaths accounted 
for 4.9% of stillbirths in 2012 (Table 3.2). 
Comparable data showed that the proportion 
of stillbirths alive at the onset of care in labour 
was higher in Scotland at 8.6%.63 In 11 (3.6%) 
cases of stillbirth it was not known if the baby 
was alive at the onset of care in labour and in 
three (27.3%) of these cases the baby was born 
before arrival to hospital.
 n(%)
Baby alive at onset of care in labour 15(4.9%)
Baby not alive at onset of care in labour 266(87.5%)
Never in labour 12(3.9%)
Not known 11(3.6%)
Table 3.2: Life status of baby at the onset of care in labour for stillbirths in 2012
4 4  PERINATAL MORTALIT Y IN IREL AND ANNUAL REPORT 2012 
Table 3.3: Stillbirth main cause of death in 2011 and 2012, NPEC Classification System
Stillbirths 2011 2012
 N=318 N=304
Major congenital anomaly 81(25.5%) 80(26.3%)
          Central nervous system 10 11
          Cardiovascular system 10 5
          Respiratory system - 1
          Gastro-intestinal system 3 2
          Musculo-skeletal system 3 1
          Multiple anomalies 10 10
          Chromosomal disorders 39 38
          Metabolic disorders - -
          Urinary tract 2 2
          Other major congenital anomaly 4 10
Infection 17(5.3%) 16(5.3%)
Maternal  
          Bacterial 1 -
          Syphilis 1 -
          Viral diseases - 2
          Protozoal - -
          Group B Streptococcus 2 1
          Other maternal infection - -
Ascending infection  
          Chorioamnionitis 13 11
          Other ascending infection - 2
Maternal disorder 6(1.9%) 0(0.0%)
         Pre-existing hypertensive disease 1 -
         Diabetes 2 -
         Other endocrine conditions - -
         Thrombophilias - -
         Obstetric cholestasis - -
         Drug misuse - -
         Uterine anomalies 1 -
         Other maternal disorder 2 -
Specific placental conditions 52(16.4%) 73(24.0%)
          Placental insufficiency 18 17
          Fetal thrombotic vasculopathy 7 8
          Placenta infarction 6 12
          Massive perivillous fibrin deposition - -
          Vasa praevia - 2
          Velementous insertion 2 -
          Retroplacental Haemorrhage - 5
          Thrombosis in fetal circulation - 5
          Villitis - 4
          Other placental condition 19 20
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Table 3.3: Stillbirth main cause of death in 2011 and 2012, NPEC Classification System (Contd.)
 2011 2012
Mechanical 20(6.3%) 25(8.2%)
          Prolapse cord 1 1
          Cord around neck 8 14
          Other cord entanglement or knot 11 10
          Uterine rupture before labour - -
          Uterine rupture during labour - -
          Mal-presentation - Breech - -
          Mal-presentation - Face - -
          Mal-presentation - Compound - -
          Mal-presentation - Transverse - -
          Mal-presentation - Other - -
          Shoulder dystocia - -
Associated obstetric factors 7(2.2%) 3(1.0%)
          Intracranial haemorrhage - -
          Birth injury to scalp - -
          Fracture - -
          Other birth trauma - -
          Intrapartum asphyxia 5 -
          Polyhydramnios - -
          Oligohydramnios - -
          Premature rupture of membranes - -
          Spontaneous premature labour - 2
          Other obstetric factors 2 1
Hypertensive disorders of pregnancy 4(1.3%) 2(0.7%)
          Pregnancy induced hypertension 1 -
          Pre-eclampsia toxaemia 3 2
          HELLP syndrome - -
          Eclampsia - -
Antepartum or intrapartum haemorrhage 35(11.0%) 21(6.9%)
          Praevia 2 -
         Abruption 33 21
         Uncertain haemorrhage - -
Specific fetal conditions 15(4.7%) 9(3.0%)
         Twin-twin transfusion 5 4
         Feto-maternal haemorrhage 5 2
         Non immune hydrops 3 -
          Iso-immunisation - -
         Other fetal condition 2 3
Intra-uterine growth restriction 17(5.3%) 6(2.0%)
          IUGR - Suspected antenatally 4 4
          IUGR - Observed at delivery 7 1
          IUGR - Observed at post mortem 6 1
Unexplained 64(20.1%) 69(22.7%)
          No antecedents or associated obstetric factors 41 30
          Antecedents or associated obstetric factors present 20 38
          Very limited information available - -
          Pending post mortem or other investigation 3 1
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Cause of early neonatal death
The cause of early neonatal deaths was 
classified using both the NPEC Neonatal 
Classification System and the NPEC Maternal 
and Fetal Classification System in order to 
identify both the primary neonatal condition 
causing the death and the underlying main 
antecedent or obstetric factor associated with 
the death.
Major congenital anomaly was the primary 
cause of death of half (n=68, 48.2%) of the 
141 early neonatal deaths (Figure 4.1). 
Respiratory disorder was the only other common 
main cause of death, accounting for one in 
three (n=44, 31.2%) early neonatal deaths. 
Neurological disorder was the main cause in 9.9% 
of cases. Two deaths (1.4%) were unexplained. A 
detailed listing of the main cause of death for the 
141 early neonatal deaths is given at the end of 
this section of the report.
4. Early neonatal deaths: Specific findings
Figure 4.1: Primary cause of early neonatal death (upper chart) and detailed cause in cases of respiratory disorder 
(lower left-hand chart) and cases of major congenital anomaly (lower right-hand chart)
?
?
?
?
?
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Major congenital anomalies
The type of major congenital anomaly that 
caused 68 of the 141 neonatal deaths is 
illustrated in Figure 4.1. One in four were due 
to a chromosomal disorder (n=17, 25.0%), one 
in five (n=13, 19.1%) were due to anomalies 
related to the urinary tract and a similar 
proportion were due to multiple abnormalities. 
Central nervous system and cardiovascular 
system anomalies each accounted for a 
further 10% of these deaths. In neonatal 
deaths attributed to a chromosomal disorder, 
the diagnosis was made by cytogenetic 
analysis in three quarters of cases (n=13 of 
17, 76.5%).
Respiratory disorders
Of the 44 early neonatal deaths caused by 
respiratory disorder, two-thirds (n=29, 65.9%) 
were due to severe pulmonary immaturity. 
Surfactant deficiency lung disease caused 
nine neonatal deaths (Figure 4.1). All but five 
of the 44 early neonatal deaths attributed 
to respiratory disorder occurred in babies 
delivered between 22 and 27 weeks gestation 
(Table 4.1). This pattern of gestational age was 
in marked contrast with the early neonatal 
deaths due to major congenital anomaly and 
those due to other causes (Table 4.1).
Neurological disorders
A neurological disorder was attributed as the 
main cause of 14 early neonatal deaths. For 
ten of these 14 cases, the condition involved 
was hypoxic ischaemic encephalopathy 
(HIE). Nine of the ten HIE cases occurred in 
babies with a gestational age of 37-41 weeks. 
An autopsy was performed in all but one of 
these neonatal deaths (n=8; unknown for one 
case) and seven were coroner cases. Table 
4.2 details the gestational age, customised 
birthweight centile and main antecedent or 
obstetric factor associated with the 14 early 
neonatal deaths attributed to neurological 
disorders.
Broad main cause of death <22 22-27 28-31 32-36 37-41 ≥42 
 weeks weeks weeks weeks weeks weeks
Respiratory disorder – 39 4 1 – –
  (88.6%) (9.1%) (2.3%)  
Major congenital anomaly – 2 9 35 22 –
  (2.9%) (13.2%) (51.5%) (32.4%) 
Other 1 3 6 4 13 1 
 (3.6%) (10.7%) (21.4%) (14.3%) (46.4%) (3.6%)
Table 4.1: Gestational age distribution in neonatal deaths by broad main cause of death in 2012
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Neurological  Gestational age  Birthweight centile Main antecedent or obstetric factor 
Disorder   associated with the death
IVH/PVH 24 52nd Spontaneous premature labour
IVH/PVH 26 90th Spontaneous premature labour
HIE 33 25th Placental abruption
HIE 37 8th Placental disease
HIE 40 48th Placental disease
HIE 40 74th Placental disease
HIE 39 89th Unexplained
HIE 41 51st Unexplained
HIE 41 64th Unexplained
HIE 38 49th Ascending infection- chorioamnionitis
HIE 40 66th Nuchal cord
HIE 38 3rd Other maternal disorder
Other 32 91st Other maternal disorder
Other 41 4th Fracture
Note: IVH/PVH = Intraventricular/periventricular haemorrhage; HIE = hypoxic ischaemic encephalopathy
Table 4.2: Details of early neonatal deaths due to neurological disorders in 2012
Condition and management at birth
The NPEC Perinatal Death Notification Form 
records the condition, in terms of respiratory 
activity and heart rate shortly after delivery, of 
babies who die in the neonatal period. For half 
of these babies (n=72, 51.1%), spontaneous 
respiratory activity was absent or ineffective 
at five minutes following delivery and for one 
third (n=49, 35.3%, unknown for two cases) 
the heart rate was persistently less than 100 
beats per minute.
In two-thirds of the cases of early neonatal 
death, active resuscitation was offered in 
the delivery room (Table 4.3). In almost 
three quarters of the cases where active 
resuscitation was not offered (n=36, 70.6%) 
major congenital anomaly was the cause of 
death and a further 17.7% (n=9) were attributed 
to severe pulmonary immaturity or were pre-
viable (<22 weeks gestation).
More than half of the babies were admitted to a 
neonatal unit in the hospital of delivery (Table 
4.3). This varied depending on whether active 
resuscitation had been offered in the delivery 
room. Admission to a neonatal unit followed 
more than three quarters of the cases offered 
active resuscitation compared to one in four 
not offered active resuscitation. Twenty-four 
babies (17.1%) were transferred to another unit.
Management Active resuscitation offered * All
 Yes (89, 63.6%) No (51, 36.4%) 140 (100%)
Baby admitted to neonatal unit 72 (81.8%) 13 (25.5%) 85 (61.2%)
Baby transferred to another unit 15 (16.9%) 9 (17.6%) 24 (17.1%)
*Active resuscitation in the delivery room includes BMV, PPV, intubation, cardiac massage. 
Note: Information unknown for two cases.
Table 4.3: Management of neonate at birth in babies who died within the first week of life
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Age of neonate at death
Almost two thirds of the early neonatal deaths 
occurred within 24 hours of delivery (Table 
4.4). Major congenital anomaly and severe 
pulmonary immaturity were the main cause 
of death in 51.2% (n=44) and 36.0% (n=31) of 
these cases, respectively.
Completed days 0 1 2 3 4 5 6
Number 84 20 12 7 11 3 4
% 59.6 14.2 8.5 5.0 7.8 2.1 2.8
Cumulative % 59.6 73.8 82.3 87.2 95.0 97.2 100
Table 4.4: Age of neonate at death
Location of neonatal death
The vast majority of early neonatal deaths 
occurred either in the labour ward or in the 
neonatal unit (Table 4.5). One in ten deaths 
occurred in a paediatric centre.
Place of death n(%)
Home* 3(2.1%)
Labour ward 43(30.5%)
Neonatal unit 69(48.9%)
Ward of the maternity unit 11(7.8%)
Paediatric centre 15(10.6%)
Table 4.5: Location of neonatal death
*These babies were delivered in a maternity unit.
All 43 neonatal deaths that occurred in the 
labour ward occurred within 24 hours of 
delivery. These 43 deaths in the labour ward 
accounted for half (51.2%) of the 84 neonatal 
deaths that occurred in the first day. A further 
36.9% (n=31) first day neonatal deaths 
occurred in a neonatal unit. As detailed in Table 
4.4, the daily number of neonatal deaths was 
significantly lower once 24 hours had elapsed 
after delivery. Two-thirds of the neonatal 
deaths after 1-6 completed days happened in a 
neonatal unit (n=38 of 57, 66.7%) and a further 
one in five of these deaths (n=12, 21.1%) 
happening in a paediatric centre (Figure 4.2).
Figure 4.2: Place of neonatal death 0-6 complete days after birth
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While not included in the calculation 
of perinatal mortality rates, we ask for 
notification of deaths in the early neonatal 
period of babies born before 24 weeks 
gestation and weighing less than 500g. 
For 2012, 20 such deaths were reported by 
four maternity units. These maternity units 
accounted for almost 40% of births in Irish 
maternity units in 2012. Using this proportion 
would give a national estimate for 2012 of 50 
early neonatal deaths of babies born before 
24 weeks gestation with a birthweight less 
than 500g.
Using the NPEC Neonatal Classification 
System, the assigned cause of death was 
pre-viable (<22 weeks) for 12 cases, severe 
pulmonary immaturity for seven cases 
and pneumonia for one case. Based on 
the NPEC Maternal and Fetal Classification 
System, the antecedent or associated 
obstetric factors in these 20 early neonatal 
deaths were ascending infection (n=8), 
premature rupture of membranes (n=6), 
spontaneous premature labour (n=3), twin-
twin transfusion (n=2) and other placental 
condition (n=1).
The birthweights of the babies were in the 
range 240-485g and their gestation at 
delivery was 19-23 weeks. There was strong 
evidence of fetal growth restriction based 
on the customised birthweight centiles 
calculated for 19 of the 20 babies. All but two 
(n=17, 89.5%) were small-for-gestational-
age (SGA; <10th centile) and 16 (84.2%) 
were severely SGA (<3rd centile). All died 
within 24 hours of being delivered and all 
but one died in the labour ward. For 17 of the 
20 babies (85.0%), spontaneous respiratory 
activity was absent or ineffective at five 
minutes following delivery and the heart rate 
was also persistently less than 100 beats 
per minute. Active resuscitation was not 
offered in the delivery room and none were 
admitted to the neonatal unit.
Information about autopsy was reported 
for 17 of the 20 deaths. An autopsy was 
performed in four cases, an offer of autopsy 
was made in another six cases and there 
were seven cases where an autopsy was not 
offered. Placental histology examination was 
conducted for 19 of the 20 deaths (unknown 
for one case).
Early neonatal deaths <500g birthweight and <24 weeks gestation
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Table 4.6: Early neonatal main cause of death in 2011 and 2012, NPEC Classification System
 2011 2012
 N=138 N=141
Major congenital anomaly 71(51.4%) 68(48.2%)
          Central nervous system 15 7
          Cardiovascular system 8 7
          Respiratory system 2 2
          Gastro-intestinal system 2 2
          Musculo-skeletal system 2 2
          Multiple anomalies 8 12
          Chromosomal disorders 20 17
          Metabolic disorders (in-born errors of metabolism) 1 2
          Urinary tract 6 13
          Other major congenital anomaly 7 4
Pre-viable (<22 weeks) - 1(0.7%)
Respiratory disorders 45(32.6%) 44(31.2%)
          Severe pulmonary immaturity 39 29
          Surfactant deficiency lung disease - 9
          Pulmonary hypoplasia 3 1
          Meconium aspiration syndrome - -
          Primary persistent pulmonary hypertension - 1
          Chronic lung disease/bronchopulmonary dysplasia - -
          Other respiratory disorder 3 4
Gastro-intestinal disease 1(0.7%) 3(2.1%)
          Necrotising enterocolitis 1 2
          Other gastro-intestinal disease - 1
Neurological disorder 7(5.1%) 14(9.9%)
          Hypoxic-ischaemic encephalopathy 6 10
          Intraventricular/periventricular haemorrhage - 2
          Other neurological disorder 1 2
Infection 6(4.3%) 4(2.8%)
          Sepsis 4 2
          Pneumonia - 1
          Meningitis - -
          Other infection 2 1
Injury/Trauma - -
Other specific causes 2(1.4%) 3(2.1%)
          Malignancies/tumours - -
          Other specific cause 2 3
Sudden unexpected deaths 1(0.7%) 2(1.4%)
          SIDS 1 2
          Infant Deaths - Cause Unascertained - -
Unexplained 5(3.6%) 2(1.4%)
          No antecedents or associated obstetric factors - 1
          Antecedents or associated obstetric factors present - -
          Very limited information available 5 -
          Pending post mortem or other investigation - 1
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The investigation of perinatal deaths due to 
intrapartum events is valuable in assessing 
quality of care. These deaths are unexpected 
and include stillbirths alive at the onset of 
professional care in labour and neonatal 
deaths. Traditionally intrapartum deaths 
referred to babies who were alive at onset 
of labour but stillborn. The inclusion of 
neonatal deaths facilitates the assessment 
of all perinatal deaths that may have an 
intrapartum origin.
We reviewed perinatal deaths reported for 
2011 and 2012 focusing on babies with a 
gestational age of at least 34 weeks and a 
normal birthweight (2,500-4,500g) whose 
death was not due to major congenital 
anomaly, infection or placental abruption. In 
total, there were 24 such deaths suggesting a 
rate of 0.16 per 1,000 births (95% confidence 
interval: 0.10-0.23 per 1,000) or one in 6,084 
births in Ireland. The gestation at delivery 
was at least 37 weeks for all 24 babies and 
the deaths occurred in 11 of the 20 maternity 
units operating in the country in 2011 and 
2012. While the numbers are too small to 
draw conclusions, no maternity unit had an 
outlying rate.
Eleven deaths occurred in 2011 (six stillbirths 
and five early neonatal deaths) and 13 in 
2012 (two stillbirths and 11 early neonatal 
deaths). While the 13 deaths accounted for 
just 2.9% of the 445 perinatal deaths reported 
to this audit for 2012, they accounted for one 
in eight (12.3%) of the 106 cases of perinatal 
death with normal birthweight and gestation 
of at least 37 weeks. A post mortem was 
undertaken for all but one of the 13 deaths in 
2012 and ten became coroner cases. Details 
of the 13 deaths in 2012 are provided in Table 
5.1.
5. Perinatal deaths associated with intrapartum events
Type of Gestational age Birthweight Main antecedent or Neonatal cause
perinatal (weeks) centile obstetric factor of death
death   associated with the death
SB 40 24th Unexplained1 Not applicable
SB 41 49th Intrapartum uterine rupture,  Not applicable
   previous caesarean section 
ENND 39 89th Unexplained1 HIE
ENND 40 48th Other placental condition HIE
ENND 41 14th Unexplained2 Unexplained2
ENND Unknown Unknown Unbooked, born at home Unexplained3
ENND 39 63rd Unexplained1 SIDS
ENND 41 64th Unexplained1 HIE
ENND 41 51st Unexplained1 HIE
ENND 41 4th Birth trauma Intracranial haemorrhage
ENND 38 3rd Non-obstetric maternal haemorrhage HIE
ENND 40 66th Nuchal cord HIE
ENND 40 74th Other placental condition HIE
Note: SB=Stillbirth; ENND=Early neonatal death; Unexplained1=no antecedents or associated obstetric factors; Unexplained2=pending results of post 
mortem or further information; Unexplained3=some antecedents or associated obstetric factors; HIE=hypoxic ischaemic encephalopathy; SIDS=Sudden 
Infant Death Syndrome
Table 5.1: Details of perinatal deaths in 2012 associated with intrapartum events
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Data relating to 40 late neonatal deaths 
occurring in 2012 were reported to the 
NPEC for the purposes of this clinical audit. 
At the time of writing finalised figures for 
late neonatal deaths in 2012 were not yet 
published by the Central Statistics Office. In 
the five most recent years for which data are 
available, 2007-2011, the annual number of 
late neonatal deaths fluctuated between 29 
and 41 with no discernible trend. Thus, the 
number of late neonatal deaths reported to 
the NPEC is consistent with the CSO figures 
for recent years. However, maternity hospitals 
may not be notified of the late neonatal death 
of a baby delivered in their unit if the baby was 
transferred to a paediatric unit or discharged 
home. The NPEC is working with colleagues 
in the relevant hospitals (maternity and 
paediatric) to address this issue.
Given the notification issue and the limited 
number of late neonatal deaths reported, this 
section of the report provides a brief summary 
of the submitted data as well as the detailed 
listing of the main cause of the 40 deaths 
according to the NPEC Classification System.
Similar to early neonatal deaths, the most 
common cause of late neonatal death was 
major congenital anomaly (n=15, 37.5%) and 
the next most common cause was respiratory 
disorder (n=9, 22.5%), specifically severe 
pulmonary immaturity. For just two (5.0%) 
of the late neonatal deaths the main cause of 
death was unexplained.
Table 6.1 describes a range of characteristics 
of the babies who died in the late neonatal 
period. There were similar proportions of male 
(n=18, 45.0%) and female (n=22, 55.0%) 
babies among those who died in the late 
neonatal period. This is in contrast with 2011 
when three quarters of the babies were male 
(n=26 of 35, 74.3%).
Most of the babies who died in the late neonatal 
period in 2012 were born by spontaneous 
vertex delivery (n=22, 55.0%); 35.0% (n=14) 
were delivered by caesarean section. Almost 
half (n=18, 45.0%) had a gestational age of 37 
weeks or more at birth but two-thirds (n=27, 
67.5%) had a birthweight less than 2,500 
grams. More than 40% of the babies were small 
for gestational age (SGA; <10th centile) and 
one in three were severely SGA (<3rd centile).
The proportion of late neonatal deaths decreased 
across the second (57.5%), third (25.0%) and 
fourth (17.5%) weeks of life. This pattern was 
also observed in 2011 when 42.9%, 28.6% and 
22.9% of late neonatal deaths occurred in weeks 
two, three and four, respectively.
In 2012, seven of the babies died at home or 
in transit home (17.5%), almost half (n=18, 
45.0%) died in the neonatal unit and one third 
died in a paediatric centre (n=14, 35.0%). 
Respectively, 8.6%, 45.7% and 45.7% of late 
neonatal deaths in 2011 occurred at home, in 
the neonatal unit and in a paediatric centre.
6. Late neonatal deaths: Specific findings
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Table 6.1: Characteristics of late neonatal deaths, 2012
  N=40
Infant sex
 Male 18 (45.0)
 Female 22 (55.0)
Mode of delivery
 Spontaneous vertex delivery 22 (5.0)
 Pre-labour caesarean section 10 (25.0)
 Caesarean section after onset of labour 4 (10.0)
 Forceps 1 (2.5)
 Assisted breech 2 (5.0)
 Ventouse 1 (2.5)
Gestational age at delivery 
 22-27 weeks 15 (37.5)
 28-31 weeks 1 (2.5)
 32-36 weeks 6 (15.0)
 37-41 weeks 18 (45.0)
Birthweight 
 500<1000g 16 (40.0)
 1000<1500g -
 1500<2000g 5 (12.5)
 2000<2500g 6 (15.0)
 2500<3000g 5 (12.5)
 3000<3500g 4 (10.0)
 3500<4000g 1 (2.5)
 4000g+ 3 (7.5)
Customised birthweight centile category 
 Zero 10 (25.0)
 <3rd 13 (32.5)
 <10th 17 (42.5)
 10-49th 13 (32.5)
 50-89th 6 (15.0)
 90th+ 4 (10.0)
Timing of death 
 2nd week of life 23 (57.5)
 3rd week of life 10 (25.0)
 4th week of life 7 (17.5)
Location of death 
 Home (after delivery in a maternity unit) 6 (15.0)
 Ward of the maternity unit 1 (2.5)
 Neonatal unit 18 (45.0)
 In transit home 1 (2.5)
 Paediatric centre 14 (35.0)
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Table 6.2: Late neonatal main cause of death in 2011 and 2012, NPEC Classification System
  2011 2012
  N=35 N=40
Major congenital anomaly 20(57.1%) 15(37.5%)
 Central nervous system 2 2
 Cardiovascular system 5 5
 Respiratory system 1 1
 Gastro-intestinal system 1 -
 Musculo-skeletal system 1 -
 Multiple anomalies 1 2
 Chromosomal disorders 6 4
 Metabolic disorders - -
 Urinary tract - -
 Other major congenital anomaly 3 1
Pre-viable (<22 weeks) - -
Respiratory disorders 5(14.3%) 9(22.5%)
 Severe pulmonary immaturity 5 5
 Surfactant deficiency lung disease - 1
 Pulmonary hypoplasia - -
 Meconium aspiration syndrome - -
 Primary persistent pulmonary hypertension - -
 Chronic lung disease/bronchopulmonary dysplasia - -
 Other respiratory disorder - 3
Gastro-intestinal disease 2(5.7%) 6(15.0%)
 Necrotising enterocolitis 2 5
 Other gastro-intestinal disease - 1
Neurological disorder 2(5.7%) 1(2.5%)
 Hypoxic-ischaemic encephalopathy 1 -
 Intraventricular/periventricular haemorrhage - -
 Other neurological disorder 1 1
Infection 4(11.4%) 4(10.0%)
 Sepsis 4 3
 Pneumonia - -
 Meningitis - -
 Other infection - 1
Injury/Trauma - -
Other specific causes - -
 Malignancies/tumours - -
 Other specific cause - -
Sudden unexpected deaths - 3(7.5%)
 SIDS - 3
 Infant Deaths - Cause Unascertained - -
Unexplained 2(5.7%) 2(5.0%)
 No antecedents or associated obstetric factors - -
 Antecedents or associated obstetric factors present - -
 Very limited information available 2 2
 Pending post mortem or other investigation - -
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Ms Bridget Boyd, Assistant Director of Midwifery, Coombe Women & Infants University Hospital
Nominated by Elizabeth Adams, Deputy Nursing Services Director, HSE
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Nominated by the Faculty of Paediatrics
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Dr Siobhan Gormally, Consultant Paediatrician Our Lady of Lourdes Hospital
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Nominated by Elizabeth Adams, Deputy Nursing Services Director, HSE
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Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
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Ms Patricia Williamson, Assistant Director of Midwifery, Rotunda Hospital
Nominated by Elizabeth Adams, Deputy Nursing Services Director, HSE
Prof Richard Greene, Consultant Obstetrician/Gynaecologist, Cork University Maternity Hospital
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Ms Edel Manning, Research Midwife, National Perinatal Epidemiology Centre
Perinatal Mortality Project Manager
Ms Jennifer Lutomski, Epidemiologist, National Perinatal Epidemiology Centre
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National Perinatal Epidemiology Centre contributor
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National Perinatal Epidemiology Centre contributor
Appendix A: Perinatal Mortality Group members
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Appendix B: Hospital co-ordinators and contributors
Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed,   Dr Salah Aziz,Ms Margaret Mulvany, 
 Ms Evelyn McAdam Ms Joanne McGrath, Ms Karen Malocca
Coombe Women and Dr Chris Fitzpatrick
Infants University Hospital  
Cork University Ms Katie Burke, Ms Rhiona Cotter, Dr Keelin O’Donoghue, 
Maternity Hospital  Ms Siobhan Foley Dr Brendan Murphy
Kerry General  Ms Claire Fleming Kelliher, 
Hospital, Tralee Ms Mary Stack Courtney 
Letterkenny General Hospital Ms Raphael Dalton, Ms Mary Doherty,  Ms Evelyn Smith
 Ms Geraldine Hanley, Ms Mary Lynch
Mayo General Hospital,  Ms Pauline Corcoran,  Dr Hilary Ikele, 
Castlebar Ms Diane Brady Dr Meabh Ní Bhuinneain
Midland Regional Hospital, Mullingar Ms Marie Corbett 
Midland Regional Hospital, Portlaoise Ms Ita Kinsella,
 Ms Michelle Mahon 
Mid-Western Regional Ms Sandra O’Connor, Ms Margaret Quigley
Maternity Hospital, Limerick Ms Margo Dunworth 
Mount Carmel Hospital, Dublin Ms Catherine Halloran,  Dr Valerie Donnelly
 Ms Felicity Doddy
National Maternity Hospital, Dublin  Ms Geraldine Duffy, Dr Rhona Mahony
 Ms Fionnuala Byrne Dr Eoghan Mooney
Our Lady of Lourdes Ms Anne Keating Dr Seosamh Ó Cóigligh
Hospital, Drogheda 
Portiuncula Hospital, Ballinasloe Ms Mairead Hynes, 
 Ms Karen Leonard 
Rotunda Hospital, Dublin Ms Ruth Ritchie, Ms Aileen Murphy Dr Sam Coulter Smith
Sligo General Hospital Ms Juliana Henry Dr Heather Langan
South Tipperary General  Ms Siobhan Kavanagh
Hospital, Clonmel  
St Luke’s Hospital, Kilkenny Ms Connie McDonagh 
University Hospital Galway Ms Marie Hession 
Waterford Regional Hospital Ms Margaret Coe, Ms Emer Denn
 Ms Paula Curtin, 
Wexford General Hospital Ms Helen McLoughlin 
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Appendix C: Perinatal Death Notification Form 2011
1 
 
 
  
 
PERINATAL DEATH NOTIFICATION FORM 
2012  
 
CHOOSE Type of Case (TICK) 
  STILLBIRTH: A baby delivered without signs of life from 24 weeks’ gestation and/or with a birth weight of ≥ 
500g. 
 
 *If the birth occurred unattended and there was no lung aeration seen at Post Mortem (PM) and no other 
circumstantial evidence of life at birth, it should be assumed that the baby was stillborn.  
 
 
OR 
 EARLY NEONATAL DEATH: Death of a live born baby occurring before 7 completed days after birth. 
 
OR 
 LATE NEONATAL DEATH:  Death of a live born baby occurring from the 7th day and before 28 completed 
days after birth. 
 
 
* For the purpose of reporting, a ‘live born’ baby is defined as any baby born with evidence of life such as  
breathing movements, presence of a heart beat, pulsation of the cord or definite movement of voluntary 
muscles.   
 
  *If a baby born at <22 completed weeks is being registered as a neonatal death, please report same to 
NPEC. 
 
 
 
 
 
 
 
The National Perinatal Epidemiology Centre is sincerely grateful for your contribution to this 
audit. 
 
Guidance for completing this form, with specific reference to Sections 11, 12 and 13 on Cause 
of Death, is outlined in the accompanying reference manual. 
 
The National Perinatal Epidemiology Centre also acknowledges with thanks the Centre for Maternal and Child 
Enquiry (CMACE) UK for permission to modify and use its Perinatal Mortality Notification Proforma for use in the 
Irish context.  
 
For NPEC Office use only:  
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2 
 
SECTION 1.  WOMANS’ DETAILS  
       1.1. Mother’s age   
1.2. Ethnic group: 
     White - Irish                               Irish Traveller  
            Any other White background         Please specify country of origin _____________________________________  
      Asian or Asian Irish                    Black or Black Irish    
     Other including mixed ethnic backgrounds: Please specify  ______________________________________________      
            Not recorded 
         
        1.3. What was the woman’s occupation at booking? 
 
 ___________________________________________________________________________________________________   
 
1.4. What was the occupation of the woman’s partner at booking?                     
 
                ___________________________________________________________________________________________________  
 
 1.5. Level of education completed by this woman: 
        Primary or less      Secondary                Third Level               Unknown   
 1.6. Height at booking (round up to the nearest cm):  
 1.7. Weight at booking (round up to the nearest kg):    
 If weight is unavailable, was there evidence that the woman was too heavy for hospital scales?  Yes  No 
 1.8. Body Mass Index at booking (BMI):  . 
 
 1.9.a. Did the woman smoke at booking?      Yes, specify quantity smoked per day__________________ 
                               No                     Unknown 
 1.9.b. Did she give up smoking during pregnancy?             Yes             No          Unknown     N/A 
 
 1.10. Is there documented history of alcohol abuse?  
        None recorded                  Prior to this pregnancy                  During this pregnancy  
 
           
       1.11. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?  
              None recorded                  Prior to this pregnancy                  During this pregnancy  
SECTION 2.  PREVIOUS PREGNANCIES  
2.1. Did the woman have any previous pregnancies?    If yes, please complete questions 2.2-2.4                 Yes        No 
2.2. No. of completed pregnancies ≥24 weeks and or with a birth weight ≥ 500g (all live and stillbirths):   
2.3. No. of pregnancies <24 weeks and with a birth weight < 500g:         
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3 
2.4. Were there any previous pregnancy problems? If yes, please tick all that apply below  Yes  No 
       Three or more miscarriages  Pre-term birth or mid trimester loss         Stillbirth, please specify number   
       Infant requiring intensive care    Baby with congenital anomaly              Neonatal death, please specify number   
Previous caesarean section Placenta praevia               Placental abruption      
Pre-eclampsia (hypertension &  proteinuria)          Post-partum haemorrhage requiring transfusion 
Other, please specify_______________________________________   Unknown 
 
SECTION 3.  PREVIOUS MEDICAL HISTORY 
3.1. Were there any pre-existing medical problems? If yes, please  tick all that apply below    Yes  No Unknown 
Cardiac disease (congenital or acquired)  Epilepsy  
Endocrine disorders e.g. hypo or hyperthyroidism  Renal disease 
Haematological disorders e.g. sickle cell disease       Psychiatric disorders 
Inflammatory disorders e.g. inflammatory bowel disease  Hypertension  
Diabetes  Other, please specify  ________________________  
 
SECTION 4.  THIS PREGNANCY 
4.1. Final Estimated Date of Delivery (EDD):      //      Unknown 
  Use best estimate (ultrasound scan or date of last menstrual period) based on a 40 week gestation, or the final date agreed 
in the notes. 
4.2. Was this a multiple pregnancy at the onset of pregnancy?  Yes  No  
4.3. Date of first booking appointment:   //      Not booked  
 
4.4. Intended place of delivery at booking:  Name of unit _________________________________ 
 
Please specify the type of unit  
  Obstetric Unit      Alongside Midwifery Unit               Home                   Unbooked 
 
4.5. What was the intended type of delivery care at booking?  
         Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
         Home c/o Hospital DOMINO Scheme  
SECTION 5.  DELIVERY 
      
       5.1. Onset of labour: 
 Spontaneous          Induced  Never in labour  
 
5.2. Intended place of delivery at onset of labour:  Name of unit ____________________________ 
  
Please specify the type of unit 
 Obstetric Unit    Alongside Midwifery Unit     Home 
       
       5.3. What was the intended type of care at onset of labour?  
 Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
 Home c/o Hospital DOMINO Scheme 
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5.4. Was the intended mode of delivery a planned caesarean section?    Yes    No  
 
5.5. Place of delivery: Name of unit ____________________________________  
 
Please specify the type of unit 
  Obstetric Unit             Alongside Midwifery Unit                         Home 
 
5.6. What was the type of care at delivery?  
 Obstetric-Led Care        Midwifery -Led Care              Born Before Arrival (BBA) - Unattended      
 Self-Employed Community Midwife       Home c/o Hospital DOMINO Scheme                             
       5.7. Date and time of delivery/birth:  Date: //       Time:: 
 
5.8. What was the presentation at full dilation?  
Vertex  Breech  Compound (includes transverse and shoulder presentations)  Brow  Face    
5.9. What was the presentation at delivery?  
Vertex  Breech  Compound (includes transverse and shoulder presentations) Brow  Face    
 
5.10. What was the mode of delivery? (Please tick all that apply) 
Spontaneous Vaginal     Ventouse           Lift-Out Forceps        Mid-Cavity Forceps        Rotational Forceps         
Assisted Breech delivery         Pre-Labour Caesarean Section                 Caesarean Section After Onset of Labour 
 
CAESAREAN SECTIONS ONLY 
 
5.11. What was the type of or indication for Caesarean Section? 
Elective - At a time to suit woman or maternity team Urgent - Maternal or fetal compromise which is not immediately life threatening    
Emergency - Immediate threat to life of woman or fetus          Failed instrumental delivery 
  
SECTION 6.  ALL BABY OUTCOME 
      6.1. Sex of fetus/baby:     Male    Female     Indeterminate  
      6.2. Number of fetuses/babies in this delivery: (all identifiable including papyraceous)                                                   
             Birth order of this fetus/baby:   
Singleton  
 Twin 1  Twin 2   
 Triplet 1  Triplet 2                 Triplet 3  
Other multiple birth pregnancy, please specify__________         Birth Order   
       
        6.3. If from a multiple delivery, what was the chorionicity? Please tick all that apply 
Dichorionic diamniotic  Monochorionic diamniotic   Monochorionic monoamniotic Trichorionic   Not known 
       
        6.4. Birth weight (kg):  .  
 6.5. Gestation at delivery:  weeks + days                        Unknown 
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       6.6. Was this a termination of pregnancy?   Yes  No 
              Please refer to the reference manual, page 2   
 
INTRAPARTUM-RELATED EVENTS ONLY 
       6.7. Was a local hospital review of this case undertaken?      Yes  No 
 
SECTION 7. MATERNAL OUTCOME 
       7.1. Admission to HDU:                                                                                                                           Yes    No  
       7.2. Admission to ICU:                                                                                                                             Yes    No  
       7.3. Maternal Death:                                                                                                                                 Yes    No 
   
SECTION 8. STILLBIRTH (If not a stillbirth, please go to Section 9) 
      8.1. At what gestation was death confirmed to have occurred?  weeks + days  
      If known, what date was death confirmed?  // 
 
      8.2. Was the baby alive at onset of care in labour?   
Yes                    No                Never In Labour                    Unattended       Unknown 
 
SECTION 9. NEONATAL DEATH ONLY 
       9.1. Was spontaneous respiratory activity absent or ineffective at 5 minutes?    Yes  No 
If a baby is receiving any artificial ventilation at 5 minutes, the assumption is absent/ineffective activity: a 0 Apgar score indicates 
absent activity.  
 
 
       9.2. Was the heart rate persistently <100bpm? ( i.e. heart rate never rose above 100bpm before death)  
                                                  Persistently <100bpm Rose above 100bpm 
      
       9.3. Was the baby offered *active resuscitation in the delivery room?                                             Yes  No 
        (*active resuscitation includes BMV, PPV, intubation, cardiac massage) 
 
 
        9.4. Was the baby admitted to a neonatal unit? (Includes SCBU and ICU)                                          Yes  No 
        9.5. Was the baby transferred to another unit after birth?                                                                   Yes  No 
   
        9.6. Date and Time of Death:                                                Date //       Time : 
 
        9.7. Place of Death*:            Labour Ward               Neonatal Unit                 Ward          
                                                In Transit                     Paediatric Centre           Home     
 
                                                           Name of unit:_____________________________________________ 
 
*This question refers to where the baby actually died, e.g. ‘ICU, ‘at home’ or ‘in transit’.  
 Babies are deemed to have died ‘at home’ if there are no signs of life documented in the home even if resuscitation is attemp ted. 
 A baby is deemed to have died ‘in transit’ if signs of life are documented prior to transfer but the baby was either declared dead on arrival to 
the hospital or showed no subsequent signs of life in the hospital, despite attempted resuscitation. . 
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SECTION 10. POST-MORTEM  
       10.1. Was this a coroner’s case? If yes, please complete question 10.2.                                                   Yes   No  
10.2. Has the post-mortem report been received from the coroner’s office?                                   Yes   No 
         If no, please complete question 10.3.                                      
                                                                                                               
       10.3. Please specify which coroner’s jurisdiction this case was assigned to: _____________________________ 
                                            
 
 
10.4. Was a post-mortem performed?                                                                                   Yes  No 
         If no, please complete question 10.5. 
10.5. Was a  post-mortem offered?                                                                                        Yes  No 
 
10.6. Were any of the following procedures carried out after death?  
               Please tick all that apply    
         MRI                      X-Ray                  CT                    External Examination           
       10.7. Was the placenta sent for histology?                                                                                         Yes  No 
SECTION 11. CAUSE OF DEATH AND ASSOCIATED FACTORS - STILLBIRTH & NEONATAL DEATH  
 
  11. Please TICK ALL the maternal or fetal conditions that were present during pregnancy or were  
associated with the death.  PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        11.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases      
 
 Other major congenital anomaly, please specify ________________________________________________________________ 
 
 Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                               Cytogenetic analysis *                  Ultrasound                 
                                                      *See reference manual, page 2 
 
        11.1.2. HYPERTENSIVE DISORDERS OF PREGNANCY: 
 
Pregnancy induced hypertension    Pre-eclampsia  HELLP syndrome     Eclampsia  
 
        11.1.3. ANTEPARTUM or INTRAPARTUM HAEMORRHAGE:    
 
Praevia   Abruption   Cause uncertain 
 
 
        11.1.4. MECHANICAL:    
 
Cord compression:  Prolapse cord  Cord around neck    Other cord entanglement or knot 
Uterine rupture: Before labour During labour 
Mal-presentation: Breech                     Face  Compound  
 Transverse Other, please specify  ____________________________________  
        Shoulder dystocia:  
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        11.1.5. MATERNAL DISORDER:       
    Pre-existing hypertensive disease   Diabetes     Other endocrine conditions (excluding diabetes)        
    Thrombophilias   Obstetric cholestasis  Uterine anomalies                       
    Connective tissue disorders, please specify______________________________________________________________________________ 
    Other, please specify_______________________________________________________________________________________________ 
 
        11.1.6. INFECTION: (confirmed by microbiology/placental histology)   
 
Maternal infection:  Bacterial    Syphilis    Viral diseases    
 Protozoal                                        Group B Streptococcus 
                                Other, please specify organism  _______________________________________________________ 
Ascending infection: 
                                                         Chorioamnionitis    Other, please specify  _________________________________ 
 
        11.1.7. SPECIFIC FETAL CONDITIONS:    
Twin-twin transfusion       Feto-maternal haemorrhage    Non-immune hydrops    Iso-immunisation    
Other, please specify ___________________________________________________________________________________________________  
 
        11.1.8. SPECIFIC PLACENTAL CONDITIONS:   
 
No abnormal histology reported 
Vasa praevia      Velamentous insertion                             Massive perivillous fibrin deposition   
Placental infarction           →           Please specify approximate percentage involved _______________ 
       Chorioamnionitis              →           Mild                             Moderate                          Severe 
       Fetal vasculitis             →          Arterial                    Venous                        Both      
Retroplacental haemorrhage    →    Please specify approximate percentage of maternal surface involved _______________ 
Thrombosis in fetal circulation   →   Please specify if arterial or venous _______________ 
       Villitis                     →                      Mild                             Moderate                         Severe 
Other, please specify_______________________________________________________________________________________________ 
 
        11.1.9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE:     YES   
         
          What was this based on? Please tick all that apply 
 Suspected antenatally                    Observed at delivery                         Observed at post-mortem      
        11.1.10. ASSOCIATED OBSTETRIC FACTORS: Please tick all that apply   
        Birth trauma             Intracranial haemorrhage                         Subgaleal haematoma    
                                  Fracture, please specify_____________________________________________________ 
                                  Other, please specify________________________________________________________________________________ 
 Intrapartum fetal blood sample result < 7.25       Yes     No 
 
      Polyhydramnios                  Oligohydramnios            Premature rupture of membranes     
      Prolonged rupture of membranes (> 24hours)                Amniocentesis                             
   Spontaneous premature labour                 Other, please specify_____________________________________________________   
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       11.1.11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS:       
  
 
 
 
 
 
 
 
 
  
        11.1.12. UNCLASSIFIED: Please use this category as sparingly as possible   
 
SECTION 12.  MAIN CAUSE OF DEATH: STILL BIRTH & NEONATAL DEATHS 
 
     12.1. Which condition, indicated in Section 11 as being present, was the MAIN condition or sentinel event          
causing or associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem  
report, please refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 
with but not necessarily causing the death”).   
 
 
 
 
 
 
 
 
   12.2. Was the cause of death question completed using a placental histology report or a post-mortem report?  
               Please tick all that apply  
                 Post Mortem             Placental Histology              Both              Neither 
 
       
SECTION 13. NEONATAL DEATH ONLY:  NEONATAL CONDITIONS ASSOCIATED WITH THE DEATH 
 
 
       13.1. Please TICK ALL the neonatal conditions causing and associated with the death.  
                PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        13.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases                              
  
Other major malformation, please specify ________________________________________________________________ 
 
 
Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                                     Cytogenetic analysis *                  Ultrasound                 
                                                              *See reference manual 
 
        13.1.2. PRE-VIABLE: (less than 22 weeks)           
 
        13.1.3. RESPIRATORY DISORDERS:    
 
   Severe pulmonary immaturity    Surfactant deficiency lung disease Pulmonary hypoplasia Meconium aspiration syndrome    
 
   Primary persistent pulm. hypertension          Chronic lung disease / Bronchopulmonary dysplasia (BPD)   
   Other (includes pulmonary haemorrhage), please specify____________________________________________________________________ 
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        13.1.4. GASTRO-INTESTINAL DISEASE:    
 
Necrotising enterocolitis (NEC)    Other, please specify __________________________________________________________________ 
 
 
        13.1.5. NEUROLOGICAL DISORDER:   
 
Hypoxic-ischaemic encephalopathy (HIE)                                                  
 
*Intraventricular / Periventricular haemorrhage, please specify highest grade (0 – 4) *           
    Hydrocephalus*,  please tick all that apply: 
                   * Congenital              Acquired                     Communicating                   Obstructive       Other__________________            
 
 
Other, please specify______________________________________________________________________________________________ 
 
 
        13.1.6. INFECTION:   
 
Generalised (sepsis)     Pneumonia      Meningitis       
Other, specify ______________ 
 
 
        13.1.7. INJURY / TRAUMA: (Postnatal)     
  
 
             Please specify_______________________________________________________________________________________________________ 
 
 
        13.1.8. OTHER SPECIFIC CAUSES:   
 
Malignancies / Tumours              In-born errors of metabolism, please specify ___________________________________ 
Specific conditions, please specify___________________________________________________________________________ 
 
 
        13.1.9. SUDDEN UNEXPECTED DEATHS:   
 
Sudden Infant Death Syndrome (SIDS)        Infant death – Cause unascertained 
 
        13.1.10. UNCLASSIFIED: (Use this category as sparingly as possible)   
 
 
      13.2. Which condition, indicated in Section 13.1 as being present, was the MAIN condition causing or 
associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem report, please 
refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors  that were associated 
with but not necessarily causing the death”).   
 
 
 
 
 
 
  
 
     
      13.3. Was the cause of death question completed using a placental histology or a post-mortem report?  
                Please tick all that apply  
              
 
            Post Mortem             Placental Histology              Both              Neither 
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Appendix D: Cause of Death Guidance and Definitions
Guidance and Definitions for Completion of Section 11 
CAUSE OF DEATH - STILLBIRTH AND NEONATAL DEATH 
DEFINITION OF TERMS Subcategory 
1. MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death 
 
Central nervous system    
Cardiovascular system 
Respiratory system  
Gastro-intestinal system  
Musculo-skeletal anomalies 
Multiple anomalies   
Chromosomal disorders 
Metabolic diseases  
Urinary tract 
Other 
2. HYPERTENSIVE DISORDERS OF PREGNANCY. 
 
Pregnancy induced hypertension 
Pre-eclampsia 
HELLP syndrome 
Eclampsia  
3. ANTEPARTUM OR INTRAPARTUM HAEMORRHAGE. After 20 w gestation, whether 
revealed or not. If associated with PET, APH will be a secondary diagnosis. Ignore minor degrees 
of haemorrhage (e.g. ‘shows’, cervical polyps etc). Recurrent bleeding of uncertain origin followed 
by preterm labour should not be ignored. 
Praevia 
Abruption 
Uncertain 
 
4. MECHANICAL. Any death attributed to uterine rupture, deaths from birth trauma or intrapartum 
asphyxia associated with problems in labour such as cord compression, malpresentation, 
shoulder dystocia etc. 
Antepartum deaths associated with cord entanglement in the absence of strong circumstantial          
evidence that cord compression caused death should be classified as having no associated 
factor. 
 
Cord Compression  
Prolapse cord  
Cord around neck 
Other cord entanglement or knot 
Uterine Rupture  
Before labour 
During labour 
Mal-presentation 
Breech / Transverse   
       Face / Compound 
Other  
Shoulder dystocia 
5. MATERNAL DISORDER. Specify hypertensive disease present before pregnancy or any 
other maternal disease or condition sufficient to jeopardise the baby such as diabetes, cardiac 
disease etc.  
Infection is classified separately. 
 
Pre-existing hypertensive disease  
Diabetes  
Other endocrine conditions 
Thrombophilias   
Obstetric cholestasis   
Drug misuse    
Uterine anomalies 
Connective tissue disorders / Other  
6. INFECTION. Confirmed by microbiology / placental histology. 
Specify maternal infections sufficient to have compromised the baby which may be associated 
with      congenital infection of the baby. Trans-placental transmission may have occurred such as 
CMV, toxoplasmosis etc.  
Specify only those ascending infections that are a significant factor in death. Chorioamnionitis 
sufficient to cause preterm birth may be specified for some neonates but evidence of fetal 
infection may be required as an explanation of stillbirth.  
Maternal infection 
Bacterial / Viral diseases  
Syphilis  /Group B Streptoccus  
Protozoal 
Other 
Ascending infection  
Chorioamnionitis 
Other 
7. SPECIFIC FETAL CONDTIONS. Document only those specific conditions arising in the fetal 
period. 
 
 
Twin-twin transfusion   
Feto-maternal haemorrhage 
Non-immune hydrops 
Iso-immunisation 
Other 
8. SPECIFIC PLACENTAL CONDITIONS. Specific placental conditions sufficient to cause 
death or be associated with fetal compromise such as IUGR. These will often be secondary to 
other maternal conditions e.g. PET. 
Cord problems associated with compression will normally be classified under ‘Mechanical’ 
Placental infarction   
Retroplacental haemorrhage         
Thrombosis in fetal circulation 
Chorioamnionitis 
Vilitis  
Fetal vasculitis 
Massive perivillous fibrin deposition 
Vasa praevia / Velementous insertion 
Other 
9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE. IUGR may be 
suspected antenatally by abdominal circumference (AC) less than the centile threshold used to 
define IUGR locally, or decreased AC growth velocity, +/- oligohydramnios. 
Suspected antenatally 
Observed at delivery 
Observed at post mortem 
10. ASSOCIATED OBSTETRIC FACTORS. Factors recorded as Other Associated Obstetric 
Factors will be important clinical or pathological features of the pregnancy or baby but will not be 
an explanation of the death; they will often be secondary to other maternal or fetal conditions. 
Birth trauma and/or Intrapartum asphyxia should normally be classified primarily by the underlying 
cause (e.g Mechanical ). Birth Trauma and/or other antenatal/intra-partum factors can be 
recorded here either as a secondary factor or when there is no underlying explanation. 
 
 
Birth Trauma 
Intracranial haemorrhage 
Birth injury to scalp 
Fracture 
Other 
Intrapartum fetal blood 
sample <7.25 
Other 
Polyhydramnios 
Oligohydramnios 
Premature rupture of membranes 
Spontaneous premature labour 
Other 
11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no 
explanation or significant associated factor. 
 
12. UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery and 
which cannot be fitted into any of the above categories. Use as sparingly as possible.  
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Guidance and Definitions for Completion of Section 12: 
CAUSE OF DEATH – NEONATAL DEATH ONLY 
The following definitions and associated subcategories will help you choose the relevant 
neonatal conditions causing and associated with death. 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death. 
Central nervous system 
Cardiovascular system 
Respiratory system 
Gastro-intestinal system 
Musculo-skeletal system 
Multiple anomalies 
Chromosomal disorders 
Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE. Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS. Severe pulmonary immaturity will encompass those babies 
where structural lung immaturity is so gross as to mean ventilatory support is unsustainable at the 
outset, usually babies between 22 – 24w gestation. Surfactant Deficient Lung Disease may 
include babies with clinical or pathological evidence of hyaline membrane disease.  
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary haemorrhage) 
GASTRO-INTESTINAL DISEASE. Many babies with NEC will have associated sepsis which 
may be given as a secondary cause.  
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER. HIE includes those babies with severe hypoxic-ischaemic 
brain injury before birth. If possible, please specify if HIE was primarily of intrapartum or 
antepartum origin. Specify periventricular leukomalacia only if this is a significant factor in the 
infant death. Birth Trauma will usually be classified here.  
Hypoxic-ischaemic encephalopathy (HIE) 
Intraventricular/Periventricular haemorrhage 
Other 
 
INFECTION. Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is congenital (i.e. 
acquired ante or intrapartum acquired) or neonatal in origin. 
Generalised (sepsis) 
Pneumonia 
Meningitis 
Other 
 
INJURY / TRAUMA. Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will 
usually be classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
OTHER SPECIFIC CAUSES. Death due to specific fetal and neonatal conditions such as 
isoimmunisation or unexplained hydrops. Neonatal conditions will include aspiration, unexplained 
pulmonary haemorrhage.  
Malignancies/Tumours 
Specific conditions 
SUDDEN UNEXPECTED DEATHS. SIDS should conform to the accepted definition. 
Unascertained are those unexpected deaths that are not explained despite a full investigation 
including autopsy, but do not conform to the accepted definition of SIDS. 
Sudden Infant Death Syndrome (SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or delivery and 
which cannot be fitted into any of the above categories. Please use this category as sparingly as 
possible.  
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